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“To define is to limit.” 
O. Wilde, 1890. 
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Introduction 
 
Nanotechnologies  
 
Nanotechnologies are a rapidly growing industry and it is expected to reach a market size of 
approximately 26 billion dollars by 2015
 
(BCC Research, 2011). Engineered nanomaterials (NMs) 
are on the nanoscale level range ca. 1-100 nm, with high reactivity and surface area. NMs showed 
peculiar physico-chemical properties (optical, magnetical, dielectrical, of density and mechanical 
resistance) and for those reasons are currently used in different areas such as electronics, 
biomedicine, pharmaceuticals, cosmetics, environmental analysis and remediation, catalysis and 
material sciences. There are also NMs ubiquitously in the environment resulting from natural and 
anthropic processes. Despite some recently acquired knowledge on the effects of NMs on human 
toxicology and to a lesser extent of their ecotoxicology, very little is known about mechanisms of 
biological uptake and interaction with cells of living organisms (US National Research Council, 
2012) as well as between environmental and biological compartmentalization and chemical 
behavior in the environment (Ju-Nam et al., 2008; Rico et al., 2011, Lowry et al., 2012). Since the 
early nineties there has been a huge interest in NMs, regarding their structure, their physico-
chemical properties and their relative toxicity. Only recently the problem of their ecotoxicity (Kahru 
et al., 2010) has been raised and few studies are moving in this direction. Recent studies on NMs 
provide an initial basis for evaluating the primary issues in a risk assessment framework of 
nanomaterials (Tsuji et al., 2006), highlighting points as the identification of the hazard through  
chemical composition, physico-chemical properties, interactions with tissues, and potential 
exposure levels. The procedure will be variable, considering the nature of the particle case-by-case, 
and the legislation in force.  
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Figure 1. Risk assessment framework for nanomaterials (published on Tsuji et al., 2006). 
 
Current legislation 
 
Legislation concerning NMs is currently under consideration since the variable nature of the 
molecules investigated. On February 10, 2009, European Food and Safety Authority (EFSA) 
adopted a scientific opinion on “The potential risks arising from nanoscience and nanotechnologies 
on food and feed safety” in response to the growing need of regulation of those materials. The first 
guidance was released from EFSA scientific committee on May 10, 2011 concerning the risk 
assessment of the application of nanoscience and nanotechnologies in food chain and feed (EFSA, 
2011), in which the attention was focused on the evaluation of the methodologies relevant for all the 
phases of the risk assessment procedure (Tsuji et al., 2006),  in six general cases here reported: i) no 
persistence of NMs in preparations/formulations as marketed, ii) no migration from food contact 
materials, iii) complete NMs transformation in the food/feed matrix before ingestion, iv) 
transformation during digestion, v) information on non-nanoform available, vi) no information on 
non-nanoform available. The guidance underlined how, currently, there are no in vitro methods 
validated to be used for hazard assessment of NMs. However, in vitro tests may provide 
information on hazards, give indication of potential toxicity of an NM and may be used to elucidate 
possible mode of action, understanding biological responses and mechanisms involved. Absorption, 
distribution, metabolism and excretion parameters are likely to be influenced by both the chemical 
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composition of the NM as well as its physico-chemical properties (size, shape, solubility, surface 
charge and surface reactivity). Conversely, United States Food and Drug Administration (FDA), on 
April 2012 approved two different draft guidance concerning regulation of nanomaterials in food 
and cosmetics, allowing de facto the use of ZnO NMs and TiO2 NMs for sunscreens. On July 26, 
2013, the European Commission’s (EC) Scientific Committee on Consumer Safety (SCCS) posted 
two documents available for comments regarding legislation of ZnO and TiO2 NMs, still under 
consideration. On December 20, 2013, European Joint Research Center releases online a web 
platform for the purpose of share and increase the current knowledge concerning nanomaterials 
both for physico-chemical characterization of the pollutant and also risk assessment procedure 
(http://ihcp.jrc.ec.europa.eu/our_databases/web-platform-on-nanomaterials). 
 
Current knowledge concerning NMs exposure in plants 
 
Several experiments has led to understand the transport mechanisms and accumulation of Ag NMs 
in Arabidopsis thaliana (L.) Heynh both on the physiological and molecular point of view (Geisler-
Lee et al., 2013; Kaveh et al., 2013). Ag NMs mechanisms of response were also investigated in 
crop species, as Cucurbita pepo (L.) (Stampoulis et al., 2009; Musante et al., 2010; Hawthorne et 
al., 2012). Effects on seed germination and roots growth and uptake of ZnO NMs in Lolium 
perenne (L.) and Glycine max (L.) Merr has been partially elucidated
 
(Lin et al., 2007; Lin et al., 
2008; Lopez-Moreno et al., 2010; Hernandez-Viezcas et al., 2013). Some studies have shown the 
ecotoxic effect of TiO2 NMs (Menard et al., 2011; Servin et al., 2012) and the effect of TiO2 NMs 
on human health has been studied because of the widespread use in food and in personal care 
products (Weir et al., 2012). 
In conclusion, as reported in most of the current literature, the mechanisms involved in uptake and 
translocation of NMs in the plant tissues and their physico-chemical forms inside the plant still 
remain largely unknown (Rico et al., 2011). 
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Figure 2. Uptake, translocation, and biotransformation pathway of various nanoparticles in a plant system: plant 
showing the selective uptake and translocation of nanoparticles (left); transverse cross section of the root absorption 
zone showing the differential nanoparticle interaction on exposure, published on Rico et al., 2011 (right). 
 
 
Yeast as model system for the investigation of NMs toxicity 
 
Similarly to plants, the mechanisms involved in NMs toxicity in yeast are still actually unknown. 
Furthermore, the variability of NMs behavior, along the different types of treatment applicable to 
yeast strains, led to increase the level of general complexity of the experimental approach used. 
Several studies performed on yeast revealed the extreme variability of effects ascribable to different 
categories of NMs (Kasemets et al., 2009), focusing the attention to several properties implicated in 
toxicity. Differences observed in the NMs responses may caused by stability of the single NM 
tested: CuO NM, for instance, showed an intrinsic instability of the particle, highlighting how the 
toxic effect consist in the Cu
2+
 release. In this context it was also analyzed the effect of CuO NM on 
some yeast strains deleted in genes involved in the detoxification pathway of Cu
2+ 
(Kasemets et al., 
2012). Conversely, the behavior of ZnO NM, characterized by a considerable size, becomes much 
similar to the bulk material for itself.     
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Other types of NMs, as TiO2, did not shown toxic effect below 20 g L
-1
. There is not only to 
consider the effect of the NM properly said since also the coat of the particle can have a major role 
in the toxic response. The functionalization of Au NMs, that until now were considered as 
completely non toxic, showed a response implicated in the respiratory metabolism (Smith et al., 
2013). In this already complex scenario it is necessary to consider also the primary role of the yeast 
cell wall in the NMs translocation inside the cytoplasm.    
 
 
Cadmium Sulphide Quantum Dots (CdS QDs) 
 
Among the many categories of NMs more diffuse on the market are the Cadmium sulfide based 
quantum dots (CdS QDs) (Fig.3). Their sizes are among the smaller (less than 10 nm). In addition 
to their size/volume ratio, the distribution of charge over the surface was found to be a key issue in 
the application of QDs as components of semiconductor electrodes (Favero et al., 2006; Martínez-
Castañón et al., 2005; Zhai et al., 2010). They find application in electronic components as cell 
phones, stereo Hi-Fi, general hardware for informatics. Functionalized CdS QDs (with L-cysteine, 
or glutathione) are used as water-soluble and biocompatible fluorescent probes both for chemicals 
(silver ion labeling), as reported in Chen et al., 2005, and protein labeling (Huang et al., 2011). 
Since their physico-chemical properties, CdS QDs are also used in the synthesis of monolithic 
aerogels comprising cadmium sulfide nanoparticles partially coated with metallic silver (Gill et al., 
2009), which are the basis of the next-gen photovoltaic panels. The uncertainty on the effects of 
NMs is of concern for the citizens health and Regulatory Institutions  increasing the need of 
environmental health and safety (EHS) research dedicated to understand the potential toxicity of 
NMs for humans and environment. 
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Figure 3. Representation of unrelaxed and relaxed cubic CdS nanoparticles, published on Favero et al., 2006 (left); 
TEM image of the CdS QDs, published on Martínez-Castañón et al., 2005 (right). 
 
 
Aim of the project 
 
The aim of this work was to apply a genome-wide approach to determine the toxicity and the 
mechanism of CdS QDs using different model species as Arabidopsis thaliana (L.) Heynh 
(accession Landsberg erecta) and Saccharomyces cerevisie. Mutagenized lines of these organisms 
were also used for an in vivo study to study the effects and toxicity of cadmium as a bulk material, 
such as in CdSO4, from that of CdS QDs. At present, there is not a general consensus on the 
differences related to the toxicity of metal ions and their derived NMs. One of the goal was to 
identify detoxification pathways in A. thaliana relative to CdS QDs that can be informative for 
other plants and for higher eukaryotes in general. A genome-wide transcriptomic analysis was 
merged with the mutant screening and genetic characterization. Data mining and system biology 
approach were used to give an interpretation of the observed phenomena. To reach information 
concerning the preservation of the tolerance/resistance mechanisms of response to CdS QDs, a 
similar genomic approach was used to investigate the phenomenon using the EUROSCARF non- 
essential knock-out mutants collection of S. cerevisiae. Preservation of the response in different 
species could provide new information about the potential toxicity of the CdS QDs and NMs in 
general.  
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Previous studies  
 
This part of the project is published in Marmiroli, Pagano et al., 2014. 
 
Manufactured nanoparticle: CdS QDs 
 
Quantum dots of the type CdS were utilized throughout the experiment, with a bulk density of 4.82 
g/cm3 and a diameter of 5 nm, synthesized according to Villani et al., 2012
 
(IMEM-CNR, Parma, 
Italy). The X-ray diffractometric spectrum of the QDs was used to establish the purity of the 
synthetic process. Cd represents the 78% of the dry weight of the nanoparticle. 
 
MIC determination for CdS QDs and CdSO4 
 
An in vitro test was used for the estimation of MIC for CdS QDs for two different wild type lines of 
A. thaliana accessions, Wassilewskija (Ws-2) and Landsberg erecta (Ler-0), both for the 
germination and for growth. Plants were grown in 25 mL Petri dishes on nutrient medium 
Murashige and Skoog (Duchefa Biochemie, Haarlem, The Netherlands) containing 1% sucrose 
solidified with agar (0.8%) under controlled temperature (24°C), humidity (30%), and photoperiod 
(16h light, 8h dark; 120 µM m
−2
 s
−1
 photosynthetic photon flux). Forty seeds were treated for assess 
germination with increasing concentrations of CdS QDs, from 40 µg L
-1
 to 300 mg L
-1
. For the 
growth test 25 seeds per dish (for four replicates) were treated for 14 d on MS medium and after 
then 25 plants were transferred to MS medium supplemented with CdS QDs, increasing 
concentrations from 40 µg L
-1
 to 300 mg L
-1
, for other 21 d of treatment. We used, as control, in 
both cases different concentration of CdSO4 (Sigma Aldrich, St. Louis, MO, USA) from 1 µM (0.11 
mg L
-1 
of Cd
2+
) to 210 µM, equal to 24.5 mg L
-1
 of Cd
2+
 (Howden et al., 1992). For the CdSO4 MIC 
was as reported in literature (Howden et al., 1992) namely 23.3 mg L
-1 
of Cd. For the CdS QDs 
MIC observed was higher in total Cd, than when using CdSO4. The MIC on seeds germination was 
higher than for growth (Fig. 5). With a concentration of 80 mg L
-1
of CdS QDs, corresponding to 
62.4 mg L
-1
of Cd
2+
, it was observed a complete leaves chlorosis and an inhibition of root growth 
(Fig. 4).  
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A control was made to exclude the possibility that the toxic effect observed was due to CdS QDs 
suspension liquid: QDs liquid suspension medium was separated by ultracentrifugation (Optima 
MAX-XP Ultracentrifuge, Beckman Coulter, Brea, CA, USA) at 50000 rpm for 20 m at  4°C and 
added to the MS medium used for germination and growth. When the nanoparticles liquid medium, 
avoid of CdS QDs, was added to seeds no inhibition of growth and germination was detected.  
 
Figure 4. The effect of CdS QDs on germination and seedling growth on wild type A. thaliana. Measurements taken 
after a 21 d exposure from 0 to 100 mg L
-1
 CdS QDs. 
 
Mutant collection screening 
 
A collection of 398 mutants lines of Arabidopsis thaliana (L.) Heynh were utilized: 234 lines of 
Wassilewskija accession with T-DNA insertion (Feldmann, 1991) and 164 lines of Landsberg 
erecta accession with maize Ac/Ds transposon insertion (Soll&Johnson collection), obtained from 
NASC (Nottingham Arabidopsis Stock Centre, UK). These lines are the product of cross between 
parental lines that contain sAc-GUS transposase, Ds element and selectable marker based on 
antibiotic resistance (streptomycin Str
R
 and hygromycin Hm
R
). The Ds element was obtained by 
substituting the central portion of Ac transposase sequence (1,77 Kb) between the restriction sites 
HindIII (1783) and XhoI (3557) with CaMV35S-Hm
R
-ocs3’, that codifies for hygromycin 
phosphotransferase gene (Bancroft et al., 1992). Ten seeds were planted for each of the 398 mutant 
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lines to test both for resistance during germination (MIC = 40 mg L
-1
) and during growth (MIC = 80 
mg L
-1
) on MS medium added with CdS QDs. The same procedure was followed with CdSO4, both 
for germination (MIC =103 µM, 11.66 mg L
-1
 of Cd) and for growth test (MIC = 207 µM, 23.33 mg 
L
-1
 of Cd). The plants were treated as previously described. During these screenings 600 Petri 
dishes were tested amounting to 19320 seeds, including replicates. To confirm the phenotypes of 
the isolated mutants the identified lines of interest were checked furtherly by testing 150 seeds for 
each line.  
Out of the 398 original mutant lines tested at CdS QDs MIC of 80 mg L
-1
 two putative 
tolerant/resistant mutants were isolated, which were named atnp01 and atnp02 (Fig. 5). Two 
different mutants resistant to lethal concentration of CdSO4, are still under investigation.  
 
 
Figure 5. Lethal concentration of CdS QDs for (a) wild type Ler-0 plants and (b) the two mutant lines atnp01 (left) and 
atnp02 (right). 
 
 
 
 
 
CdS QDs sensitive CdS QDs tolerant 
A B 
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Molecular characterization of mutant lines 
 
The genomic DNA (gDNA) was extracted from 0.5 g of plant material from the wild type line (Ler-
0) and from the two mutant lines (atnp01 and atnp02)  by 2x CTAB method (Fulton et al., 1995). 
DNA was tested for: the absence of Ac transposase, the presence and the integrity of Ds elements, 
the number Ds element copies and their position in each mutant line. The presence of the Ds 
elements inside the mutant lines was evaluated through amplification by PCR reaction of 
hygromycin phosphotransferase gene (Hm
R
) insert in the Ds element. For the evaluation of the Ds 
element integrity three overlapping sequence called Ac1-1000 (from 1 to1000 bp), Ac900-1800 (from 
900 to 1783 bp), Ac3500-4500 (from 3557 to 4500 bp) were amplified to cover, together with the Hm
R
 
gene amplicon, the complete Ds element sequence (Tab.1). The amplification protocol: 95°C for 30 
s (denaturation), 60°C for 20 s (annealing), 72°C for 90 s (amplification), for 40 cycles. Absence of 
Ac transposase was detected by amplification of the central region of transposase using the Ac900-
1800 Fwd primer  with sAc Rev primer. All these amplifications were performed on the wild type 
DNA and the two mutant lines DNAs in three biological replicates. 
 
Name Sequence Annealing T (°C) Amplicon length (bp) 
sAc Rev TTTTGACAAGATGTCCACATATCCA 61 1500 
probe Hm Fwd GCAAGGAATCGGTCAATACACT 64 700 
probe Hm Rev TCCACTATCGGCGAGTACTTCT 64  
Hm Fwd ATGAAAAAGCCTGAACTCACC 61 1000 
Hm Rev CTATTTCTTTGCCCTCGGAC 61  
Ac1-1000 Fwd CAGGGATGAAAGTAGGATGGG 64 1000 
Ac1-1000 Rev TGAGGAATGGAGTCGTAGCC 64  
Ac900-1800 Fwd GCTCTGCAACACCTGCTGAT 62 1000 
Ac900-1800 Rev AGGCTAACCACTTCATCGTACTT 62  
Ac3500-4500 Fwd GGTGCTAGACTCTGTTATTGCTG 61 1000 
Ac3500-4500 Rev AGGGATGAAAACGGTCGGTA 61  
 
Table 1. Primer sequences used to amplify segments of the Ds element in the selected A. thaliana mutants and the probe 
used for Southern hybridization to assess Ds copy number. 
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The copy number of the Ds element was determined using a colorimetric Southern blot assay: the 
probe was generated by PCR amplification of the central portion of hygromycin phosphotransferase 
gene. The probe was purified with GE Healthcare Life Science GFX™ PCR kit (Buckinghamshire, 
UK)  and quantified by Varian Cary 50 (Agilent Technologies). After quantification the probe was 
labeled by Roche DIG High Prime DNA Labeling and Detection Starter Kit I (Roche, Basel, CH). 
For each line 15 µg of gDNA were digested with restriction endonucleases EcoRI, HindIII and 
BamHI (Sigma-Aldrich, St. Louis, MO, USA) (10 U µg
-1
) overnight at 37°C. The restricted gDNA 
were separated on agarose gel 1% and blotted on Amersham Hybond N+ nylon filter (GE 
Healthcare, Buckinghamshire, UK). The hybridization with the probe for Hm and the colorimetric 
detection were performed with Roche DIG High Prime DNA Labeling and Detection Starter Kit I. 
The position of the Ds elements for each mutant line was determined by genome walking; 0.5 µg of 
genomic DNA for each line were digested with restriction endonucleases EcoRI, and MseI (20 U 
µg
-1
) and ligated with the adapters for 4h at 37°C. The Genome Walking protocol of Ausubel et al., 
1994 was followed (Tab. 2). 
 
Name Sequence Annealing T (°C) 
Adapter EcoRI GTAATACGACTCACTATAGGGCACGCGTGGTTTAA - 
Adapter MseI GTAATACGACTCACTATAGGGCACGCGTGGTAT - 
AP1 GTAATACGACTCACTATAGGGC 67 
AP2 ACTATAGGGCACGCGTGGT 72 
5’ GSP1 CGGTGAAACGGTCGGGAAACTAGCTCT 67 
3’ GSP1 CAAAAATACCGGTTCCCGTCCGATTTC 67 
5’ GSP2 TAACGGTCGGTACGGGATTTTCCCATC 72 
3’ GSP2 CGACCGGATCGTATCGGTTTTCGATTA 72 
 
Table 2. Primer sequences and adapters used in the “genome walking” protocol to amplify flanking sequences of the Ds 
elements inserted into the selected A. thaliana mutants.  
 
The genomic library obtained was amplified in two subsequent steps to isolate the Ds element’s 
flanking regions. The amplicons obtained were cloned into an Escherichia coli plasmid (Promega 
pGem vector II, Promega, Medison, WI, USA) and sequenced.   
Amplification of the overlapping regions of the Ds element highlighted the integrity of the 
transposon sequence in both mutant lines. Moreover both amplicons sizes were as expected. The 
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amplification of the central portion of Ac transposase did not produce any amplicon. This result 
suggests that the insertion of hygromycin phosphotransferase gene into the Ds element determined 
deletion of the Ac transposase gene and consequently its loss of function. The Southern blot 
analysis gave a reliable estimation of  the copy number of Ds elements for each mutant line. The 
restriction endonuclease EcoRI and HindIII produced two hybridization bands for atnp01 and one 
band for atnp02. These results together with the genome walking analysis, demonstrate that the two 
mutant lines contained three different Ds elements. The amplification fragments produced were 
sequenced and compared in silico with Arabidopsis thaliana genome using Basic Local Alignment 
Search Tool (BLAST) algorithm (blast.ncbi.nlm.nih.gov). Alignment with Arabidopsis database led 
to the identification of six candidate genes in the two tolerant lines. In atnp01 three genes were 
putatively interested in the transposition: an unknown protein localized in the chloroplast 
(At3g46880), a calmodulin binding protein located in cytoplasm and involved in leaf development 
and meristem structural organization (DLR1), and an ELM2 (included in the MYB superfamily) 
domain-containing protein for a DNA binding protein expressed during the growth stages 
(At1g13880). The two Ds element are inserted in the At3g46880 coding sequence and between 
DLR1 and At1g13880. In atnp02 three genes identified encoded for: an O-glicosyl hydrolase located 
on endomembrane system (At3g24330), an ATP binding protein located in chloroplast (At3g24430) 
named  HCF101. The protein belongs to FSC-NTPase (4F-4S) cluster, of the P-loop NTPase 
superfamily. Several members of this superfamily play a crucial role in Fe/S cluster. The third gene 
is a pseudogene encoding for a proline-rich extensin-like receptor kinase, positioned between the 
two foregoing genes (At3g24400) The Ds element is located within the At3g24400 pseudogene.  
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Materials & Methods 
 
Determination of physiological parameters for resistant lines 
 
We measured: chlorophyll absorbance, respiratory efficiency and Cd uptake, in condition either of 
treatment with CdS QDs (80 mg L
-1
) or CdSO4 salts (23.33 mg L
-1
). Total chlorophyll was extracted 
after grinding the plants in liquid nitrogen 0.2 g for each sample, wild type line and both mutant 
lines. The powder obtained was added with 1.8 ml of acetone for 10 m in an ice bath. Chlorophyll 
absorbance at 662 nm was analyzed with a spectrophotometer Varian Cary 50 (Varian, Inc, Agilent 
Technologies, Palo alto, CA, USA) (Ni et al., 2009). Cellular respiration was estimated by TTC 
(2,3,5-triphenyltetrazolium chloride) assay (Porter et al., 1994). 0.2 g of samples from the wild type 
and from both the mutant lines were added to 3 ml TTC buffer (TTC 0.18 M, 78% Na2HPO4·H2O 
0.05 M, 22% KH2PO4 0.05 M), and incubated for 15h at 30°C. After incubation the sample was 
drained off and washed in distilled water. Each sample was extracted in 10 ml of ethanol 95% for 
10 m at 80°C. The formazan which resulted from the TTC reduction was quantified 
spectrophotometrically with Varian Cary 50 (Agilent Technologies)  (λ= 530 nm). Concentration of 
total Cd in plants was measured by FA-AAS (flame atomizer atomic absorbance spectrophotometer 
AA240FS, Agilent Technologies). The plants treated with CdS QDs (80 mg L
-1
) and CdSO4 (23.33 
mg L
-1
) were dried at 50°C for 24h. 0.2 g of each dry sample was digested with 20 ml of HNO3 for 
40 m at 200°C in a heating block (DK20, Velp Scientifica, Usmate, MB, Italy). The solution 
obtained was filtered with 0,45 µm filters (Sarstead, Nümbrecht, Germany) and analyzed by Varian 
FA-AAS (λ= 228.8 nm). 
 
Cross and segregation test of the CdS QDs resistant lines 
  
To determine stability and inheritability of the Ds element within each mutant line of interest, the 
backcrosses of the two mutants with wild type line was carried out. The mutant line was utilized as 
female (to prevent the possibility of maternal loss of the transposon) and the wild type line as pollen 
donor. Plants were grown for thirty days in soil until flowers production. After recovery of the 
pollen grains we pollinated the carpels of our mutants to obtain the F1 progeny. The seeds of F1, 
crossed with the wild type line, were grown in soil to obtain the F2 progeny. 250 seeds of  F2 
progeny, of each crossed line, were sown in vitro on hygromycin (40 µg ml
-1
). After seven days 
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from the germination these plants, grown on hygromycin (Hm
R
), were transferred on CdS QDs for a 
14 d treatment. The F2 plants growing on hygromycin and CdS QDs were tested further by utilizing 
a Genome Walking protocol, after DNA extraction, to verify the position of the Ds elements. The 
segregation of the character Hm
R
, with resistance to CdS QDs was also determined. 
   
Microarray experiments 
 
Genome-wide expression footprint of atnp01 and atnp02 as compared to the wild type in growth 
media with and without CdS QDs was determined through expression microarray. Affymetrix 
GeneChip Arabidopsis ATH1 Genome Array (Affymetrix, Santa Clara, CA, USA) containing 
22811 nuclear gene-specific tags were utilized. Seven different treatments: three for the wild type 
line, (exposed to 0 mg L
-1
, 40 mg L
-1 
and 80 mg L
-1 
of CdS QDs);  two for each of the mutant lines 
(exposed to 0 mg L
-1
, 80 mg L
-1 
of CdS QDs). Treatments were as previously described. Total RNA 
was extracted from 0.1 g of plant material with Sigma Aldrich Spectrum Plant Total RNA Kit 
(Sigma Aldrich, St. Louis, MO, USA). After spectrophotometric quantification (Varian Cary 50), 
500 ng of total RNA derived from a pool three replicates for each sample were amplified, biotin-
labeled, microarray hybridized and analyzed (Biolitix AG, Witterswill, CH). Data mining and 
system biology analysis was carried out starting from raw data. Results are available on GEO 
database (accession number: GSE53989). 
 
Real Time PCR validation 
 
Total RNA was also in this case extracted from 0.1 g of plant material with Sigma Aldrich 
Spectrum Plant Total RNA Kit (Sigma Aldrich, St. Louis, MO, USA). Reverse transcription was 
performed on 1 μg of the total RNA using the Qiagen QuantiTect Reverse Transcription kit 
(Qiagen, Velno, Netherlands). Amplifications were carried out using the Applied Biosystems Power 
SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA) in an optical 96-well plate 
with the Applied Biosystems ABI PRISM 7900HT Sequence Detection System. This system allow 
to monitoring the incorporation of the fluorescent dye SYBR Green into PCR product in real-time 
and, for each reaction, highlight the threshold cycle (Ct), defined as the PCR cycle at which 
exponential growth of PCR product is detectable. RNA retrotranscription were performed on the 
same samples used for the microarray experiments: three for the wild type line, (exposed to 0 mg L
-
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1
, 40 mg L
-1 
and 80 mg L
-1 
of CdS QDs);  two for each of the mutant lines (exposed to 0 mg  L
-1
, 80 
mg L
-1 
of CdS QDs). We designed specific primers for each gene selected from the microarray 
experiments (Tab. 3), using the Applied Biosystems SDS 2.3 software and the following thermal 
profile: 95°C for 10’, 95°C for 15” and 60°C for 60” (for 40 cycles). Primers used were assessed by 
Real Time PCR in four serial dilutions of cDNA synthesized (1, 1:10, 1:100, 1:1000).  
 
Name Sequence Annealing T (°C) 
β-actin for (HK) TCGCATGTATGTTGCCATTCA 
60 
β-actin rev (HK) ATCGAGCACAATACCGGTTGT 
GAPDH for (HK) CAGCAAAGACGCTCCATGTT 
60 
GAPDH rev (HK) GCTAGCGTTGGAGACATGTCA 
256166_AT (+) for TTCACTTATTGATGTTGCCTTATGG 
60 
256166_AT (+) rev GAGCTTTGAACTGTGCCTTGATATAG 
264735_S_AT (02+) for GGCACCTCTCTTCCAAAATCTACTA 
60 
264735_S_AT (02+) rev ACTGCTGCCGCTGTAAGTAAGAC 
aspartyl protease (+) for GGTATCAGTGTAGGCGACAAGGA 
60 
aspartyl protease (+) rev CTGTGCCTGAGTCGATTATAGCA 
ATGRP19 (01-) for GCCTCCGGTTCCTTTGGT 
60 
ATGRP19 (01-) rev TCCCTCCCTGTACGTTTCTTGTA 
ATPR2 (+) for GACACGGCCAACATCCATCT 
60 
ATPR2 (+) rev GAGTACCCTGGATCGTTATCAACA 
AWPM-19 (02+) for AGCTTCTCTACCTCATGTTGATCCAT 
60 
AWPM-19 (02+) rev GTAGCATAGTCTTGGTCTCTGTATCCA 
CYP96A15 (01-) for ATGAGACTCTACCCGCCACTTC 
60 
CYP96A15 (01-) rev TTTGTGCCCGCTTGGAA 
DDBR 1B (-) for GGTGGTTGGTGAGTATCACATAGG 
60 
DDBR 1B (-) rev TCAGGCAGCTTCATGACAAGA 
ELM2 (01+) for GCGCCACTGCAATGATCTT 
60 
ELM2 (01+) rev CTGGCAGTATTGAATCACAAGGAT 
GILT (01-) for CATGGTGAAGAGGAATGCAAAC 
60 
GILT (01-) rev TTTCTGATCGGGCCAAGTTC 
Glycosyl hydrolase (-) for CCGTCCCGCCATCCA 
60 
Glycosyl hydrolase (-) rev GGATTGCACAACGATCTTCAAA 
GSH reductase (Cd) for TGATGAGAAGAGTGATAAGGTTATTGGA 
60 
GSH reductase (Cd) rev TGCAATCCCCTGCATGATC 
Hm trans-detox (-) for GGAAGAAGTGGAAGTAGAGATGGAA 
60 
Hm trans-detox (-) rev CGTACCGCTTTCAATACCTTCTTT 
ion chan inhib  (02+) for CGGCGATGTGGGTTTCA 
60 
ion chan inhib  (02+) rev TGTTCTTACGGCAGTTCTGATCAC 
PCS (Cd) for CGGTGGTGACTGGAGTTGTG 
60 
PCS (Cd) rev GCGTCGATGGCACTAACAGA 
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PERK (02) for AAGGAAACATATCACCATCAGATCTAAA 
60 
PERK (02) rev TCCTCCAGATGAGCCATACACA 
PNP-A (01+) for TGCATTGGTGCTACATACAACTTTG 
60 
PNP-A (01+) rev CGGCAGAAATCAACTACCTTCA 
PR1 (+) for AGCTCTTGTAGGTGCTCTTGTTCTT 
60 
PR1 (+) rev CCTCGTGCCTGGTTGTGAA 
PR5( 01+) for CAGGCTGTGTCTCTGACCTCAA 
60 
PR5( 01+) rev AGGCCACGACATTGTTCTGAT 
Predicted PR (02+) for TGGATGCCGAGACACTTACG 
60 
Predicted PR (02+) rev CATTGACAACATCACCAGAGTTTG 
RmlC-like cupin (02+) for GGATCCCTAGATACTTCGCGTTTT 
60 
RmlC-like cupin (02+) rev TGGTGAATCCTACAAACTCGAATG 
RmlC-like fam (02+) for CAGCGGAGGAATGGTGTTG 
60 
RmlC-like fam (02+) rev TTGACCTCCTGTGACGTATAGCA 
2S albumin (02+) for CGACGCAGCTTAGTTCATGTG 
60 
2S albumin (02+) rev TTTGCCGCAACAATCTGTAGA 
Sulfotransferase1 (Cd) for ACAGCTCCAGCAAGTTTCTCTGA 
60 
Sulfotransferase1 (Cd) rev GCAGTGAGCATGAAGACGATGTA 
Sulfotransferase2 (Cd) for GGACACCTTGCGGTTTACGT 
60 
Sulfotransferase2 (Cd) rev AGCTTTTGAAAACAAGGGTGACTT 
AST68 (Cd+) for TCATAGGTATCAGTGTAGGCGACAA 
60 
AST68 (Cd+) rev CTGTGCCTGAGTCGATTATAGCA 
 
Table 3. Primer sequences used to amplify by Real Time PCR the target selected by microarray experiments, both for 
the wild type and the resistant mutant lines selected. (HK), housekeeping genes; (+), up-regulation in both mutants; (-), 
down-regulation in both mutants, (01+), up-regulation for atnp01 only; (01-), down-regulation for atnp01 only; (02+), 
up-regulation for atnp02 only; (Cd), cadmium response genes; (Cd+), cadmium and CdS QDs common response. 
 
 
Total proteins extraction 
 
For the proteomic profile extrapolations, atnp01 and atnp02 were compared with the wild type in 
MS medium with and without CdS QDs. Six different treatments were performed: two for the wild 
type line, two for each of the mutant lines (exposed to 0 mg L
-1
, 80 mg L
-1 
of CdS QDs). To 
facilitate the separation step, total proteins were extracted following the MgSO4 protocol (Pirondini 
et al., 2006). Total protein extracted were quantified by Bradford protein quantification method 
(Sigma Aldrich, St. Louis, MO, USA). Standard curve (λ=595 nm) was perfomed by Varian Cary 
50 (Agilent Technologies).   
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Protein separation and characterization 
 
Quantified proteins were analyzed through Beckman Coulter ProteomeLab PF2D (Beckman 
Coulter, Brea, CA, USA).  ProteomeLab PF2D consist in a two-dimensional liquid chromatography 
system based on an high-performance chromatofocusing in the first dimension and an high-
resolution reversed-phase chromatography in the second dimension. The chromatographic method 
can be used as a complementary approach to protein separation with 2D gel electrophoresis. 
 
Statistical analysis 
 
Statistics software SPSS 17.0 (http://www-01.ibm.com/software/it/analytics/spss/) was used for 
most of the statistics analysis. A two-sample t-test was used to evaluate possible variations between 
each treatment (P < 0.05) in case of chlorophyll extraction, respiratory efficiency (TTC assay) and 
cadmium uptake (FA-AAS) measured in wild type, atnp01, and atnp02. To identify deviation from 
mendelian distribution in case of the segregation for the characters of hygromycin resistance and 
CdS QDs
 
tolerance in both mutant lines a Pearson χ2 test (P < 0.05) was performed. 
Concerning microarray experiments, raw data obtained were analyzed by Affymetrix Program Suite 
Expression Console ver. 1.1 (http://www.affymetrix.com/analysis/) . A model of gene expression 
was obtained from normalized CEL intensities based on a Perfect Match only model (RMA). The 
RMA algorithm used a robust multi-array average for background adjustment, normalization, and 
log2 transformation of signal values (Irizarry et al., 2003). Normalization was performed using 
probes derived from three different housekeeping gene commonly used for the data normalization 
in plant  β-Actin and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Fig. 6, 7). A two-
sample t-test was conducted to identify differentially expressed genes. To evaluate differential gene 
expression between each treatment the differences in gene expression between the wild type 
profiles, in condition of treatment, as standard referee (calibrator) for the mutant profiles (P < 0.01) 
were performed. Differences in gene expression within each treatment were calculated again 
maintaining the wild type as the calibrator.  Heatmaps were performed with Eisen Software Labs 
Treewiev ver. 1.60 (http://rana.lbl.gov/EisenSoftware.htm, Eisen et al., 1998). Pearson correlation 
Hierarchical Clustering was performed with MeV ver. 4.7.4 (http://www.tm4.org/; Mar et al., 
2011). The profiling data sets in the context of existing knowledge was performed with VirtualPlant 
1.2 (http://www.virtualplant.org/; Katari et al., 2011) using a p-value cut-off of 0.01, AraNET 
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(http://www.functionalnet.org/aranet/; Lee et al., 2010) and Cytoscape 3.0.1 
(http://www.cytoscape.org/; Shannon et al., 2003).   
 
 
Figure 6. Log Probe cell intensity before (left) and after (right) processing with RMA algorithm.  
 
 
 
Figure 7. Density histogram of microarray raw data intensities as processed by the RMA algorithm. The y-axis denotes 
the frequency with which total RNA has a certain abundance as shown by the x-axis. The x-axis represent total RNA 
abundance in terms of the range of measured intensities. 
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The presence of a single amplicon in each Real Time PCR reaction was confirmed by dissociation 
curves. Relative expression was estimated through ΔΔCt method (Schmittgen et al., 2008), with β-
actin and GAPDH specific primers as housekeeping genes. The relative quantity of the transcript 
assayed in each RNA sample was determined by normalizing on the housekeeping genes expression 
level and calculated as an arithmetic mean of the three independent repeated reactions. Heatmaps 
concerning the wild type and the mutant lines in different conditions of treatments were performed 
with Eisen Software Labs Treewiev ver. 1.60. To evaluate differential gene expression between 
each treatment, the wild type in condition of treatment, was use as calibrator. 
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Results & Discussion 
 
Physiological parameters for resistant mutants 
 
Physiological analysis evidenced some of the features of the tolerance/resistance in the mutant lines 
atnp01 and atnp02. The AAS analysis showed, after treatment with 80 mg L
-1
 of CdS QDs, 
concentrations of total Cd uptake not statistically different in all the Arabidopsis lines (t-test, P < 
0.05). For the treatment with CdSO4 and CdS QDs the internal concentrations of Cd were not 
statistically different ranging from 4.5 mg Kg
-1
 to 5.2 mg Kg
-1
 (Tab. 4). Respiration and chlorophyll 
content in wild type and mutants have similar basal levels, but with the addition of CdS QDs (80 
mg L
-1
) in the wild type there was a complete inhibition of chlorophyll productuon and a 50% 
reduction of the respiration. In the two mutants the treatment with CdS QDs did not affect 
respiration nor chlorophyll content. Treatment with CdSO4 (23.3 mg L
-1
) inhibited chlorophyll 
production and respiration both in wild type and mutants at the same extent (Tab. 4). 
 
Samples Cd conc.a Test t Chlorophyll conc.b Test t Formazan abs.c Test t 
wt control 0.000 ± 0.020 - 1.809  ± 0.057 - 0.824  ± 0.022 - 
wt QDs 4.523  ± 0.127 - 0.017  ± 0.030 - 0.404  ± 0.009 - 
wt CdSO4 5.136 ± 0.256 - 0.051  ± 0.003 - 0.042  ± 0.012 - 
atnp01 control 0.000 ± 0.020 1.0000 1.896  ± 0.050 0.2856 0.877  ± 0.008 0.0802 
atnp01 QDs 4.503  ± 0.010 0.8248 1.862  ± 0.028 2.0211 E-05 0.902  ± 0.004 0.1650 E-04 
atnp01 CdSO4 4.660 ± 0.233 0.0031 0.059  ± 0.004 0.1296 0.041 ± 0.020 0.9366 
atnp02 control 0.000 ± 0.020 1.0000 1.783  ± 0.024 0.2966 0.869  ± 0.003 0.0603 
atnp02 QDs 5.255  ± 0.591 0.2178 1.678  ± 0.012 5.0922 E-05 1.052  ± 0.005 7.8400 E-05 
atnp02 CdSO4 4.903 ± 0.243 0.0055 0.038  ± 0.006 0.0417 0.067  ± 0.006 0.0323 
 
Table 4. Physiological parameters and Cd uptake. The effect on wild type, atnp01 and atnp02 plants exposed to 207 µM 
CdSO4 (23,33 mg L
-1
 of Cd
2+
) or 80 mg L
-1
 CdS QDs. (a) Cd concentrations in plant tissue determined by FA-AAS in 
µg g
-1 
dry weight. (b) Chlorophyll absorbance, determined spectrophotometrically, was transformed in chlorophyll 
concentration through the Lambert-Beer equation (mM). (c) Cellular respiration measured by the TTC assay. 
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Cross and segregation of the CdS QDs resistance character 
 
Genetic crosses and segregation of characters showed how the CdS QDs
 
resistance and the Hm
R 
are 
tightly bound. Considering the presence of two different Ds elements inside the mutant line atnp01 
a 9:3:3:1 (93.75%) segregation of  the character Hm
R
 was expected. For the CdS QDs
 
tolerance 
character a 3:1 (75.00%) segregation was expected because only one of the two insertions was 
considered as responsible of the resistant character. Conversely, for the second mutant line atnp02, 
with only one Ds element insertion, both the Hm
R
 and the CdS QDs resistance were considered as 
dominant characters with an expected segregation of 3:1 (75.00%). The segregation coefficients 
observed were in agreement with the parameters expected, especially for CdS QDs
 
tolerance, and 
were confirmed by the statistical analyses (Tab. 5). An amplification of the flanking regions 
performed on DNA of the resistant lines confirmed the stability of the Ds element positions inside 
the two mutant lines.  
 
Line Seeds 
Seeds 
expected 
(a) Hm 
germination 
(a)  
Expected(%) 
 (a)  
Observed(%) 
(b) CdS QDs 
growth 
(b) 
Expected(%) 
(b) 
 Observed(%) 
Pearson 
χ2 
Wild 
type 
250 0 2 0.00 0.80 0 0.00 0.00 0.1572 
F2 
atnp01 
250 234 208 93.75 83.20 208 75.00 83.20 0.0685 
F2 
atnp02 
250 187 198 75.00 79.41 198 75.00 79.41 0.3595 
 
Table 5. The table showed the results of segregation. a: percentage of germination expected considering as dominant 
the resistance to hygromycin (C= 40 µg mL
-1
). b: percentage of plant growth expected considering as dominant the 
“CdS QDs resistance” character (C= 80 mg L-1).  
 
Mutants resistant to engineered nanomaterial, in our case, were selected on Petri dishes with 80 mg 
L
-1
 CdS QDs and their growth fitness as compared with the sensitive wild type was higher (Fig. 5, 
Tab. 4) with no possibilities of the misinterpretation of tolerant/resistant phenotype. Treatments of 
A. thaliana seeds with CdS QDs in Petri dishes showed that the effect on growth was stronger than 
on germination. These results suggest that the CdS QDs could have possible difficulties in 
penetrating through the seed coat, and that only after the germination the CdS QDs could be taken 
up into the plant. When supplementing the nanoparticles liquid medium, without CdS QDs, this 
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didn’t produce any inhibition on growth, and on germination. This result suggest that the inhibition 
exercised by CdS QDs was imputable only to the CdS QDs and not to any other possible byproduct 
generated during the nanoparticles synthesis or during nanoparticle conservation in solution. This 
observation does not comply with other authors suggesting that, in some metal sulfides and metal 
selenides, oxides are formed and are the cause of the toxicity rather than the all nanoparticle 
(Hochella et al., 2008). The uptake of CdS QDs in mutants and wild type lines occurred at similar 
extent: when measuring the quantity of total Cd within the plants the results were comparable. 
These results demonstrated how the mutant lines and the wild type line had a similar Cd intake and 
excluded that tolerance/resistance was due to a mechanism of avoidance: the mutants did not 
exclude the CdS QDs. In condition of treatment with CdS QDs, the wild type line drastically 
reduced cellular respiration and photosynthetic efficiency whereas the mutant lines maintained 
normal levels (Tab. 4). When wild type and mutants were grown with CdSO4 they all took up total 
Cd at similar extents. However treatment with CdSO4 and CdS QDs had the same effect on 
chlorophyll production and respiration in wild type, but CdSO4 totally inhibited the two functions 
both in mutants and wild type. This confirms also the suggestion that in our case the metal sulfide 
did not produced ion Cd in the condition of treatment with CdS QDs. The tolerance of the mutant 
lines to CdS QDs is a true resistance which rests on some physiological and genetic mechanisms 
triggered by specific genes rather than from the exclusion of the CdS QDs and of Cd in particular. 
In our screening we have not found any CdS QDs excluder. 
 
Microarray experiments 
 
Treatment with CdS QDs of the concentration of 40 mg L
-1
 for 21 d gave information on the effects 
in non-lethal condition for the wild type. Raw analysis showed an overexpression of 23 genes in 
which the main functional class involved (21.7%) was temperature stress regulators. These results 
could represent the earlier response to the CdS QDs exposition.  
Comparison between the wild type in untreated condition with treatment at MIC (80 mg L
-1
) 
showed 148 up-regulated genes and 43 down-regulated genes; 32.4% of the genes induced by 
treatment were genes involved in detoxification: ROS (reactive oxygen species) metabolism 
(peroxidase, cytochrome P450 subunits), ion transporters, heat shock proteins, temperature stress 
regulators (Fig. 8). There were no others significant differences in wild type line between the 
response to 40 mg L
-1
 treatment and 80 mg L
-1
 treatment.  
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Figure 8. Biological processes pie chart of up-regulated genes using Gene Ontology (GO) terms of the software 
VirtualPlant in wild type exposed to CdS QDs (80 mg L
-1
). 
 
Comparison between the expression profile of the two mutant lines with the wild type at 80 mg L
-1
 
of CdS QDs showed  important transcriptomic differences. The results obtained evidenced a list of 
genes up-regulated and down-regulated in the two mutant lines. This list included genes involved in 
metabolic functions (24%), detoxification activities and stress response (22%), transporters (10%), 
reserve proteins (9%), protein synthesis (3%), DNA repair (1%), plant growth and development 
(12%), and genes with unknown function (19%). All these genes could be divided with the response 
to CdS QDs in three categories: common response, atnp01 specific response, and atnp02 specific 
response. Venn diagrams showed only a very partial overlap between the response of the wild type 
and the responses of the two mutants (Fig. 9).  
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Figure 9. Up-regulated genes (left) and down-regulated genes (right): Venn diagram showing the partial overlap with 
the wild type response and the two mutant line responses 
 
The common response included genes which were either up-regulated or down-regulated in both 
mutants. Genes showing up-regulation were: BGL2 cellulase/glucan 1,3-beta-glucosidase/hydrolase 
(At3g57260), aspartyl protease family protein (At5g10760), PR1 (At2g14610) involved in the 
defense response, and At1g36920 that codifies for a protein with unknown function. Genes 
significantly down-regulated were: DDB1B, a damaged DNA binding/protein binding (At4g21100) 
involved in embryonic development ending in seed dormancy and which may form part of a CUL4-
based E3 ubiquitin ligase; At3g28970, a copper ion transporter; At5g27780 and At1g29430, genes 
involved in auxinic response  but with unknown function.  
The atnp01 specific response included genes that in atnp01 only showed up-regulation and down-
regulation. Genes showing an up-regulation were: PR5 (At1g75040), pathogen related protein, 
At2g18660, which codifies for a EXLB3, expansin-like B3 precursor, known also as PNP-A (Plant 
Natriuretic Peptide A). PNPs are a class of systemically mobile molecules distantly related to 
expansins by their true biological role remains elusive. PNP-A contains a signal peptide domain and 
is secreted into the extracellular space. Expression profiling using microarray suggest that PNP-A 
may function as a component of plant defense response and in particular SAR, which could be 
classified as a newly identified pathogen related proteins (PRP) (Morse et al., 2004; Gehring et al., 
2003). Another important variation was in DC-1 domain-containing protein (At3g27473) with 
function of zinc ion binding involved in signaling cascades. The fourth most overexpressed gene 
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was At1g13880 (an ELM2 domain containing protein), the same gene visited by the Ds element in 
the mutant atnp01. The mutation in this gene which leads to its overexpression might be 
phenotypically translated in the expression of tolerance/resistance to CdS QDs. Between the down 
regulated genes in atnp01 the γ-interferon responsive lysosomal thiol reductase family protein/GILT 
family protein (At4g12960) with function unknown; two different glycin rich-protein, GRP17 
(At5g07530) and GRP19 (At5g07550) with function of lipid binding and a role in lipid storage and 
plant defense (Mangeon et al., 2010)
 
 Other genes were also identified:  At1g72260, a gene coding 
for a toxin binding receptor, Thi2.1, involved in the response to jasmonic acid and salicylic acid, 
jasmonic acid which mediates signaling pathway and defense response,  and At1g65340 which 
codifies for Cyp96a15, a member of the cytocrome P450 superfamily.  
The atnp02 specific response included both up- and down-regulated genes. The up-regulated genes 
were mostly related to seed reserve proteins: three different genes codifying for cruciferins were 
identified (At5g44120, At4g28520, At1g03880), three different genes that encode for oleosins 
(At3g27660, At5g40420, At4g25140), two genes for cupins (At1g03890, At2g28490), four genes for 
seed storage albumins 2S (At4G27160, At4g27140, At4g27170, At4g27150) and two different lipid 
transpost proteins (LTP) (At5g38160, At5g54740) with function of lipid binding, nutrient storage 
activity, also involved in lipid transport and pollen development. But more genes were upregulated: 
At2g15010 coding for a thionin, At2g27380, a AtEPR1 with function of structural constituent of cell 
wall, involved in plant-type cell wall modification and seed germination (Debreucq et al., 2000), 
At1g47540, which encodes for an ion channel involved in defense and other genes with unknown 
functions (At1g04560, At1g62080, At1g62000, At1g62060, At1g62220). As for the atnp02 down-
regulated genes, none exceeded the fixed threshold. Reserve proteins are believed to be implicated 
in the tolerance/resistance to CdS QDs, however, the molecular correlation with the transposition 
generated by Ds element is not certain in this case. Since CdS QDs seems to inhibit functions 
involved in protein synthesis it seems conceivable that an increase in the amount of reserve protein 
could reduce the toxic effect of CdS QDs. 
An important consideration is related to the expression level of others genes implicated by the 
transposition: in atnp01, of the three genes interested by the Ds transposition the only gene showing 
a significant level of overexpression in comparison with the wild type was At1g13880 (the ELM2 
domain-containing protein), whereas the other two genes (At3g46880, At1g13870) did not show 
statistically significant differences with the control. It is important to underline how the level of 
expression of At1g13880 is not statistically different comparing atnp01 in treated, using 80 mg L
-1
 
of CdS QDs, and untreated conditions, which could indicate a constitutive effect on the At1g13880 
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gene expression by the Ds element. A different result was found for atnp02: none of the three genes 
implicated in the transposition by the Ds element (At3g24330, At3g24430, At3g24400) showed an 
expression level statistically different comparing mutants and wild type both in condition of 
treatment. Comparing the wild type and the mutants profiles in untreated conditions, there are no 
statistically significant differences in the expression levels, with the exception of the gene 
At1g13880.  
Both mutants (atnp01 and atnp02) were backcrossed with the wild type. The F1progenies were 
grown and self-pollinated to obtain a significant F2 generation of seeds. The results of segregation 
in these F2 showed how the genetic determinism of resistance to the CdS QDs most probably rest on 
one gene in each mutant line. The segregation of resistant mutants was also consistent with 
dominance (Tab. 5), as for the segregation of the Hm
R
 character. The mutant line atnp01 has two Ds 
elements inserted but three putative genes (At3g46880, At1g13870, At1g13880) interested by a 
transposition whereas the mutant line atnp02 has one Ds element and three putative genes also 
interested by the transposition (At3g24330, At3g24430, At3g24400). It is conceivable that within 
these genes rests the expression of the resistant phenotype. To find out more about the genetic and 
molecular properties of these phenotype we have analyzed data emerging from a 24K Affymetrix 
microarray chip hybridized with aRNA (amplified RNA) from treated and untreated wild type and 
mutant lines. Different comparison were performed: wild type compared with 40 mg L
-1
 and 80 mg 
L
-1
 of CdS QDs. This first comparison was thought relevant because 40 mg L
-1
 was sublethal 
whereas 80 mg L
-1
 lethal but only for the wild type, all in untreated conditions and all in treated 
conditions with 80 mg L
-1
 of CdS QDs. The second comparison showed all in the untreated 
condition: small differences in the transcriptomic profiles of wild type and mutants were identified. 
The third comparison, between wild type and mutants in treated condition (80 mg L
-1
) showed a 
treatment specific response common to all the lines and an atnp01- and an atnp02- specific one. The 
correlation of the responses with the gene ontology is represented in the heatmap (Fig.10). The  
genes up- and down-regulated common to all conditions tested in wild type and mutants are 
represented by Venn’s diagrams (Fig. 9). 
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Figure 11. Heatmap illustrating the genes involved in the responses to CdS QDs (top) and CdSO4 (bottom). The only 
gene which showed a significant difference in expression (AST68, At5g10180) as result of exposure to CdSO4. 
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Metabolic pathways like starch, sucrose , and phenylpropanoids metabolism had genes which were 
included in the category of common response to CdS QDs, in particular BGL2 (At3g57260) also 
named AtPR2. This result is interesting for the purposes of our research because considering the 
role of 1,3-beta-glucanase in the formation of endoplasmic reticulum bodies and their role in the 
response to biotic and abiotic stress
 
(Yamada et al., 2011) could explain how the plants respond to 
CdS QDs  as to a abiotic stress. The softwares VirtualPlant, AraNET and Cytoscape allowed to 
make more specific considerations about the possible role of some of the genes previously enlisted 
after the microarray experiments, generating also a possible interaction network (Fig. 11). For 
atnp01 (Fig. 10, 12), but in particular for atnp02 (Fig. 10, 13, 14), it is possible to underline the 
main molecular functions involved. For atnp02, the implications of lipid binding proteins (p-value 
of 2.91e-7, 37.04%) and the nutrient reserve proteins (p-value of 1.78e-19, 45%) could be a key 
issue for the comprehension of the plant behavior in presence of CdS QDs. The molecular response 
of atnp02 is more complex because the metabolic implications of up-regulation of genes involved in 
reserve proteins and lipid metabolism for the establishment of the resistant phenotype could have at 
least a as important as that of an O-glicosyl transferase (of the endomembranes) and of a chloroplast 
ATP- binding protein and certainly of the pseudogene for the putative rich-extensin like receptor, 
which are the three genes evidenced after the genome walking experiment in  atnp02. There should 
be a network between the former and the latter genes (Fig. 11) in which one of the genes is epistatic 
to the function of the others, subdivided in different cluster of genes involved in CdS QDs response. 
The resulting pleiotropic effect is a regulatory cascade which induces morphological ultrastructural 
and molecular changes, essential for the resistance to CdS QDs. The overexpression of reserve 
proteins and lipid transport proteins could be a final step in this cascade with the effect of making 
cell function more independent on novel macromolecules synthesis. 
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Figure 11. Interaction network of genes involved in CdS QDs response. Generated by Cytoscape. There are appreciable 
several cluster of genes involved in the response: A, B. genes involved in plant response to pathogen activities and 
oxidative stress; C. genes involved in protein synthesis; D. genes encoding for reserve protein of the seed (atnp02 
specific). At1g13880, underlined in black, did not show any interaction known with the other genes involved in 
response. 
 
A 
B 
C 
D 
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A
B
          C 
 
Figure 12. The distribution of atnp01 upregulated genes based on Gene Ontology (GO) terms of the software 
VirtualPlant with respect to (A) biological processes, (B) molecular functions, (C) cellular components.  
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 A 
         B 
    C 
Figure 13. Biological processes. (A) molecular functions, (B) cellular components, (C) pie chart of atnp02 upregulated 
genes using Gene Ontology (GO) terms of the software VirtualPlant. It is important to highlight, among the molecular 
functions (b), the involvement of seed storage proteins, in gray, in the CdS QDs response. 
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Figure 14. Flowchart of upregulated genes of atnp02 using Gene Ontology (GO) terms of the software VirtualPlant. 
The significance of p-value increases from gray to red in the color of the boxes.  
 
Another interesting aspect are the localizations of the gene product: 60.7% of the gene products was 
localized at the level of the endomembrane system (p-value of 1.64e-9). This result confirmed the 
important role of endomembrane system in condition of stress (Matsushima et al., 2002). In the 
mutant atnp01 it is of paramount importance At1g13880 (ELM2), a putative member of the MYB 
(myeloblastosis) transcription factor superfamily, as a key factor in the regulatory networks 
controlling development, metabolism and responses to biotic and abiotic stresses (Dubos et al., 
2010). The expression levels of the MYB-related genes during the various treatments in wild type 
were generally low, most of these genes are expressed at relatively high levels during salicylic acid 
treatment
 
(Yanhui et al., 2006). Some members of the MYB family are involved in defense 
responses in plants, because salicylic acid has a major role in defense against plants pathogens. In 
condition of stress ABA signaling activates MYB-related genes which are significantly induced also 
by CdCl2 and NaCl
 
(Yanhui et al., 2006). The At1g13880 (ELM2) expression strongly increases the 
mutant atnp01 tolerance and the segregation of this gene explain almost completely the dominance 
of the character CdS QDs
 
tolerance. In this case also the up-regulation of ELM2 was associated with 
a number of other genes up- and down-regulated, specifically during the treatment, inherent to this 
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mutant only. The hypothesis of a eQT (expression- Quantitative Trait) in which ELM2 is the 
epistatic factor and some of the other genes constitute the controlled QT can be considered as 
hypothesis. The idea is that resistance to a stressor like CdS QDs could be controlled by a gene 
network with a primary gene which triggers all the cascade. The difference found between the two 
mutants lines suggest that different molecular patterns were involved in CdS QDs tolerance, but this 
does not rule out the possibility that the genetic mechanism was similar. A possible scenario is that 
both the mutants had an epistatic gene which triggers the first step of regulatory cascades (the 
overexpression of At1g13880 in atnp01, the expression of reserve proteins in atnp02) leading to 
downstream effects like those observed in atnp01 and atnp02.  
 
The cadmium salt comparison 
 
Analysis of the gene expression profiles in plant treated with Cd salts showed how the mechanisms 
of tolerance is completely different from tolerance to CdS QDs. In fact, a direct comparison in 
Arabidopsis of the genes involved in Cd response
 
(Herbette et al., 2006; Clemens, 2006) and the 
genes involved in the oxidative stress response
 
(Blokhina et al., 2010) showed that only one gene 
overexpressed in those conditions is also common to those found with our analyses (Fig. 10). This 
gene, AST68 (At5g10180), encodes for a low-affinity sulfate transporter expressed in the root cap 
and central cylinder, where it is induced by sulfur starvation. AST68 is expressed in the shoot 
vascular system and in these tissues is not induced by sulfur starvation
 
(Takahashi et al., 1997). In 
previous studies by Howden et al., 1992 A. thaliana Cd sensitive mutants were analyzed and 
showed a deficiency in synthesis of  both phytochelatyn and glutathione pathways (Howden et al., 
1995a; Howden et al., 1995b).  However, no significantly differential expressions of genes related 
to Cd tolerance, such as phytochelatyn synthetase (PCS) and glutathione reductase, were found in 
our mutants treated with CdS QDs. These results, coupled with the sensitivity of atnp01 and atnp02 
to Cd treatment, evidenced how the mechanisms of resistance to Cd ions and to CdS QDs are 
different and that the effect of treatment with CdS QDs could not merely be ascribed to the effect of 
Cd. 
 
 
 
39 
 
Real Time PCR validation 
 
Real Time PCR data analysis was performed through ΔΔCt method. Data normalization was 
performed using the same housekeeping  utilized for microarray experiments β-actin and GAPDH. 
Primers assessed showed a good level of amplification in all the dilution tested (Fig. 11, 12).  Ct 
concerning the serial dilutions of cDNA analyzed (1, 1:10, 1:100, 1:1000) were not significantly 
different from the theoretical ratio (3,3333). 
 
Figure 11: Real Time PCR amplification plot of β-actin tested in SYBR Green in serial dilution of cDNA (1, 1:10, 
1:100, 1:1000). Primers were assessed on the wild type line in absence of treatment. 
 
 
Figure 12: Real Time PCR amplification plot of GAPDH  tested in SYBR in serial dilution of cDNA (1, 1:10, 1:100, 
1:1000). Primers were assessed on the wild type line in absence of treatment. 
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Real Time PCR analyses confirmed largely the results obtained from the microarray, both in case 
of normalization with β-actin (Tab. 6, Fig. 14) and GAPDH (Tab. 7, Fig. 15). The wild type line in 
treated condition (80 mg L
-1
) was used as calibrator. Comparison between wild type and mutants  
in treated condition showed, as previously seen for the microarray results, a specific response 
common to all the lines and an atnp01- and an atnp02- specific one. Correlation of the responses is 
represented in the heatmaps (Fig.14, 15). 
GENE Wild type CNT Wild type 80 Atnp01 CNT Atnp01 80 Atnp02 CNT Atnp02 80 
1- 256166_AT (+) 5.4732 ± 1.2626 1.0000 ± 0.7037 4.8278 ± 1.0069 16.4085 ± 1.5645 5.8764 ± 0.9801 17.4669 ± 0.2324 
3- aspartyl protease (+) 2.0935 ± 1.3597 1.0000 ± 0.3310 1.0968 ± 0.1806 23.0003 ± 1.1241 0.9164 ± 0.1883 1.8036 ± 0.2258 
4- ATGRP19 (01-)  0.0309 ± 0.2161 1.0000 ± 0.4716 0.8350 ± 0.0411 2.6481 ± 0.2566 0.0154 ± 0.0739 3.4223 ± 0.3285 
7- CYP96A15 (01-) 0.2087 ± 0.1108 1.0000 ± 0.3004 0.2037 ± 0.1562 0.2633 ± 0.2573 0.0403 ± 0.1342 0.3698 ± 0.2691 
9- ELM2 (01+) 0.4017 ± 0.8931 1.0000 ± 1.2022 1.4511 ± 0.2261 3.1537 ± 0.3123 0.3490 ± 0.4073  0.4567 ± 0.0570 
10- GILT (01-)  0.0051 ± 0.8196 1.0000 ± 0.2812 0.0084 ± 0.5994 0.2842 ± 0.3190 0.0011 ± 1.0976 0.2822 ± 0.2428 
17- PNA-A (01+) 0.2962 ± 1.4600 1.0000 ± 0.4213 0.4352 ± 0.1798 13.6895 ± 0.5145 0.3197 ± 0.9167 0.6574 ± 0.3772 
18- PR1 (+) 1.2016 ± 0.8665 1.0000 ± 0.5863 3.4461 ± 0.4368 22.9432 ± 0.4639 1.0867 ± 0.6818 5.9175 ± 0.2330 
19- PR5 (01+) 1.0460 ± 0.8763 1.0000 ± 0.1988 2.1509 ± 05658 29.9607 ± 0.1977 0.9330 ± 0.5727 10.4831 ± 0.4176 
12- GSH reductase (Cd)  1.0174 ± 0.6109 1.0000 ± 0.1131 0.8207 ± 0.2148 0.9965 ± 0.4974 0.1450 ± 0.3544 0.2651 ± 0.5205 
15- PCS (Cd)  0.8888 ± 0.5835 1.0000 ± 0.2167 0.6806 ± 0.0568 1.9588 ± 0.0736 0.8555 ± 0.0904 1.4691 ± 0.1670 
24- Sulfotransferase1 (Cd) 1.3058 ± 0.2430 1.0000 ± 0.3807 0.6783 ± 0.1993  1.3149 ± 0.0506 0.7071 ± 0.0774 1.0754 ± 0.2398 
25- Sulfotransferase2 (Cd) 0.4459 ± 0.2001 1.0000 ± 0.5371 0.1258 ± 1.2400 0.1954 ± 0.1904 0.1486 ± 0.1445 0.0698 ± 0.1650 
26- Sulfur transporter (Cd+) 2.7606 ± 0.02040 1.0000 ± 0.0931 3.8771 ± 0.1172 31.5594 ± 0.0545 2.6390 ± 0.0529 5.4264 ± 0.1742 
 
Table 6: Real Time PCR result of candidates genes analyzed using β-actin for the data normalization. Data shown the 
effects on gene expression in all the condition of treatment. Wild type in condition of treatment (80 mg L
-1
) was used as 
calibrator. (+), up-regulation in both mutants; (-), down-regulation in both mutants, (01+), up-regulation for atnp01 
only; (01-), down-regulation for atnp01 only; (02+), up-regulation for atnp02 only; (Cd), cadmium response genes; 
(Cd+), cadmium and CdS QDs common response. 
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Figure 14: Heatmap representing the results of candidates genes analyzed using β-actin for the data normalization. 
Wild type in condition of treatment (80 mg L
-1
) was used as calibrator (black). Overexpressed genes are represented 
different shades of red, whereas downregulated genes are represented in green. 
 
 
GENE Wild type CNT Wild type 80 Atnp01 CNT Atnp01 80 Atnp02 CNT Atnp02 80 
1- 256166_AT (+) 0.0256 ± 0.4144 1.0000 ± 0.1484 1.6701 ± 1.1987 11.4716 ± 0.2844 12.9062 ± 0.1376 6.4085 ± 0.0762  
3- aspartyl protease (+) 1.5104 ± 0.1562 1.0000 ± 0.1637 2.2038 ± 0.4030 7.4384 ± 0.0240 1.96564 ± 0.1436 4.4382 ± 0.586 
4- ATGRP19 (01-)  0.0413 ± 0.0670 1.0000 ± 0.0311 0.1154 ± 0.1062 0.1476 ± 0.2223 0.0028 ± 0.8228 0.8150 ± 0.0500 
7- CYP96A15 (01-) 0.3014 ± 0.1127 1.0000 ± 0.1851 0.0850 ± 0.1742 0.1271 ± 0.1830 0.0977 ± 0.7554 0.5069 ± 0.0542 
9- ELM2 (01+) 1.2226 ± 0.3061 1.0000 ± 0.0917 1.9861 ± 0.1106  5.5596 ± 0.1533 1.2354 ± 0.1749 0.6759 ± 0.2760 
10- GILT (01-)  0.0010 ± 0.8196 1.0000 ± 0.2812  0.0164 ± 0.5994  0.0504 ± 0.3190 0.0064 ± 1.0976 0.9930 ± 0.2428 
17 - PNA-A (01+) 0.7169 ± 0.2169 1.0000 ± 0.6183 0.7526 ± 0.2188  6.9644 ± 0.1450 1.6701 ± 0.7404 2.7415 ± 0.0977 
18- PR1 (+) 4.1843 ± 0.8665 1.0000 ± 0.5863 5.8766 ± 0.4368  21.3327 ± 0.4636 3.9176 ± 0.6818  6.2549 ± 0.2330 
19- PR5 (01+) 0.4553 ± 0.8763 1.0000 ± 0.1988 0.7900 ± 0.5658  5.4641 ± 0.1977 0.5105 ± 0.5727 2.7510 ± 0.4176 
12- GSH reductase (Cd)  1.3899 ± 0.2422 1.0000 ± 1.1560 1.2311 ± 0.1220  2.8088 ± 0.1263 3.1711 ± 0.1849 1.8596 ± 0.2415 
15- PCS (Cd)  0.5340 ± 0.2081 1.0000 ±0.0130 0.5140 ± 0.1043  1.0643 ± 0.0582 0.8467 ± 0.1477 0.6506 ± 0.2422 
24- Sulfotransferase1 (Cd) 0.5285 ± 0.2081 1.0000 ± 0.0130 0.6484 ± 0.1043  1.0352 ± 0.0582 0.9965 ± 0.0147 0.6461 ± 0.0242 
25- Sulfotransferase2 (Cd) 0.5605 ± 0.0300 1.0000 ± 0.4957 0.5140 ± 0.2316  1.1019 ± 0.2416 0.8766 ± 0.3674 0.6551 ± 0.4336 
26- Sulfur transporter (Cd+) 1.3425 ± 0.1579 1.0000 ± 0.0264 1.5855 ± 0.0824 5.0806 ± 0.0893 1.3332 ± 0.0354 3.1166 ± 0.2602 
 
Table 7: Real Time PCR result of candidates genes analyzed using GAPDH for the data normalization. Data shown the 
effects on gene expression in all the condition of treatment. Wild type in condition of treatment (80 mg L
-1
) was used as 
calibrator. (+), up-regulation in both mutants; (-), down-regulation in both mutants, (01+), up-regulation for atnp01 
only; (01-), down-regulation for atnp01 only; (02+), up-regulation for atnp02 only; (Cd), cadmium response genes; 
(Cd+), cadmium and CdS QDs common response. 
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Figure 15: Heatmap representing the results of candidates genes analyzed using GAPDH for the data normalization. 
Wild type in condition of treatment (80 mg L
-1
) was used as calibrator (black). Overexpressed genes are represented 
different shades of red, whereas downregulated genes are represented in green. 
 
Real Time PCR results are comparable with the expression levels obtained from the microarray 
analyses. Small differences are appreciable within the comparison of the expression level of each 
gene in the various treatments, but the general trend remains unchanged. Considering for instance 
genes involved in pathogen response: PR1, which was induced in both the mutants treated, or PR5, 
pathogen related gene that showed overexpression only in case of CdS QDs treatment of atnp01, 
they maintained a similar expression profile in both cases also in Real Time analyses. Also 
considering genes involved in Cd
2+
 response, GSH reductase or PCS, used as control to evaluate 
the goodness of the analyses done, we observed an expression profile not statistically different 
from the microarray results. Only in case of AST68, gene common in both the response (Cd
2+ 
and 
CdS QDs) there are no significant differences in the expression profiles. Focusing our attention on 
relative expression level of At1g13880, gene involved in Ds element insertion and putative 
transcriptional activator of MYB family, gene resulted to be significantly overexpressed in case of 
atnp01 treated with 80 mg L
-1
 CdS QDs but not in the mutant line atnp01 in absence of treatment 
(Fig. 16, 17).  
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Fig. 16: Relative quantity of At1g13880 gene, normalization performed on β-actin. Expression level of wild type in 
condition of treatment (80 mg L
-1
) was used as calibrator. 
 
 
Fig. 17: Relative quantity of At1g13880 gene, normalization performed on GAPDH. Expression level of wild type in 
condition of treatment (80 mg L
-1
) was used as calibrator. 
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The At1g13880 (ELM2) relative expression was strongly increased in atnp01. Conversely to what 
seen previously from microarray data, up-regulation of ELM2 was associated specifically to the 
CdS QDs treatment, and not in case of absence of treatment, in which the relative expression level 
in considered not statistically different from the expression level of the calibrator (wild type 
treated). This result confirm that ELM2 gene could be an epistatic effector of the CdS QDs response 
which triggered a regulatory cascades leading to downstream effects, not as a constitutive effector 
of the response derived from the Ds element insertion but rather from the direct exposition to CdS 
QDs. 
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Saccharomyces cerevisiae  
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The use of yeast as model system 
 
Saccharomyces cerevisiae is one of the most widely used model organism for biological studies at 
cellular and molecular level. Yeast has a significant role in the field of  biotechnology: yeast exploit 
an haplo-diploid life cycle, and this allows to study also mutations in essential genes. It can be 
genetically easily manipulated and, thanks to the availability of a large set of experimental tools, it 
can also be exploited in genome-wide analyses. Furthermore yeast presents an high level of 
conservation in terms of gene functions as compared to the human genome and that of other 
eukaryotes. Yeast model system is the main contribution to the scientific community because it is  
among those organisms that allow to link genes and proteins to their function within the cell.  
After the sequencing of yeast genome, the development of post-genomic technologies and the 
possibility to use public databases (Saccharomyces Genome Database, YEASTRACT), the number 
of genes encoding for proteins which have functional information has increased from 30% to 85% 
in few years. This percentage is much higher than any other eukaryote organism. More than 
thousand yeast genes are correlated with ortholog genes involved in human diseases. Among these 
genes, the majority of human ortholog is functional in yeast and it enables to rescue the mutant 
phenotypes of the corresponding yeast strain. 
Most of the mechanisms correlated with cytotoxicity, adaptation and resistance to chemical and 
environmental stress in higher eukaryotes appear to be conserved between yeast. Changes in the 
levels of metabolites or proteins quantity following exposure to a toxic compound, can help to 
identify the cellular components and the pathways with key roles in the mechanisms of response to 
toxicity and stress. 
Saccharomyces cerevisiae is an ideal experimental platform to explain toxicity mechanisms: 
transcriptomics and quantitative proteomics are used to assess changes in gene expression of genes 
involved in the cellular response of yeast to environmental stress; metabolomics allows to study the 
metabolic profiles associated with stress response, while the chemo-genomic approach allows to 
identify the molecular targets responsible for the cytotoxic effect. These techniques must be coupled 
and integrated with appropriate bioinformatics tools to shed light on the toxicological responses to 
general stresses. 
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Materials & Methods 
 
Determination of the Minimal Inhibitory Concentration (MIC) 
 
An in vitro test was used for the estimation of MIC for CdS QDs following the EUCAST protocol 
(EUCAST, 2000). The wild type strain used was BY4742, that contain mutation in four genes 
involved in aminoacid and nucleotide synthesis (his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0). To determine 
possible implication of respiratory and metabolic pathways yeast was grown in 25 mL Petri dishes 
on different nutrient media (Sigma-Aldrich, St. Louis, MO): YPD agar 2% w/v (Yeast extract 1% 
w/v, Peptone 2% w/v, Dextrose 2% w/v), YPG agar 2% w/v (Yeast extract 1% w/v, Peptone 2% 
w/v, Glycerol 3% v/v) and SC (Synthetic Complete) agar 2% w/v (Yeast Nitrogen based 0,67% 
w/v, dextrose 2% w/v) supplemented with histidine (76 mg L
-1
), leucine (380 mg L
-1
), lysine (76 
mg L
-1
) and uracil (76 mg L
-1
) under controlled temperature (30°C). Yeast was grown starting from 
liquid cultures pre-grown in YPD at an optical density, at 600 nm [OD600], of 1.0 and diluted 200 
folds. Medium were supplemented with CdS QDs, increasing concentrations from 40 mg L
-1
 to 
1000 mg L
-1
, for 72 h. To increase the permeability of the yeast membranes and the CdS QDs intake 
we decided to supplement the growth media with increasing concentrations of nystatin from 0.1 mg 
L
-1
 to 6 mg L
-1
 (estimated in previous studies made in our laboratories). 
Nystatin (represented in figure 18) is an antibiotic, isolated for the first time in 1954 from 
Streptomyces noursei and belonging to the class of polyenic macrolides, able to bind ergosterol 
present in the fungal cell membrane and lead to the formation of pores that alter the physical 
characteristics of transport and permeability of the membrane itself. Thanks to these peculiarities, 
the use of a sub-lethal concentration of nystatin should allow an easier intake of the nanoparticles 
within the yeast cell. 
 
 
Figure 18. Structural formula of nystatin. 
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Screening of the knock out mutant collection 
 
A total of 4,688 single gene deletion mutants (non essentials for the organism life), not including 90 
strains that failed quality control and 48 slow-growth strains previously shown to exhibit a high 
false-positive rate, were utilized for genomic phenotyping. Individual plates from the deletion strain 
collection subdivided in 56 master plates of 96-well format (with one empty well, as contamination 
controls, and one wild type internal control) were inoculated into 150 μl liquid YPD (Yeast Peptone 
Dextrose) with 200 μg/ml gentamycin, G418 (Sigma-Aldrich, St. Louis, MO, US) using a VWR 96-
pin replicator (Pbi International, Milano, IT). After 2 d at 30°C, cells were inoculated onto YPD-
agar without G418, supplemented with nystatin (0,55 mg L
-1
) and supplemented, at the same time, 
with nystatin and CdS QDs (200 mg L
-1
). Replicates were performed in order to obtain a properly 
diluted inoculum (about 500 cells/pin). After 2 to 3 d at 30°C, plates were examined for sensitive 
and resistant strains according to relative colony size, followed by digital image recording. Three 
biological replicate of each treatment were performed. 
 
Spot assay 
 
To confirm the results obtained through the screening a spot assay was performed in 25 mL Petri 
dishes on YPD agar 2% w/v (yeast extract 1% w/v, peptone 2% w/v, dextrose 2% w/v) 
supplemented with CdS QDs (200 mg L
-1
) and nystatin (0,55 mg L
-1
) at 30°C for 2 to 3 d. Starting 
from cultures pre-grown in YPD at an optical density at 600 nm [OD600] of 1.0 and diluted up to 
10,000 fold in ten-fold increments before spotting.  
 
Rescue of the phenotype by complementation 
 
To investigate of the key role of genes involved in the response of CdS QDs two different genomic 
libraries of the BY4742 strain were prepared. The genomic libraries were produced according to 
Jauert et al., 2005 and inserted in a centromeric vector pRS146 (Fig. 18) and in a multicopy vector 
pRS426 (Fig.19). Escherichia coli DH5α strain was used for DNA cloning experiments. The 
individual libraries obtained were utilized for yeast transformation using the lithium acetate 
procedure (Gietz et al., 2003). To select putative rescued phenotypes, replicates were performed by 
replica plating, in 25 mL Petri dishes on agar 2% w/v (Yeast Nitrogen based 0,67% w/v) 
supplemented with 0,2% w/v yeast synthetic drop out without uracil. For the selection SC 
49 
 
(Synthetic Complete) medium was supplemented with nystatin (0,55 mg L
-1
) and nystatin 
supplemented of 200 mg L
-1 
of CdS QDs. Strains were grown for 4 to 5 d at 30°C. In order to 
confirm the results emerging from the yeast transformation, a spot assay was performed on SC 
medium supplemented with nystatin (0,55 mg L
-1
) and nystatin supplemented with CdS QDs (200 
mg L
-1
) as previously described.  
 
 
Figure 18. PRS416. Yeast centromere vector with URA3 marker and MCS derived from pBLUESCRIPT II (picture 
from www.snapgene.com). 
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 Figure 19. PRS426. Yeast episomal vector with URA3 marker and MCS derived from pBLUESCRIPT II (picture from 
www.snapgene.com). 
 
From the yeast strains which showed complemented phenotype, recombinant plasmids were 
extracted by “Smash and Grab” DNA extraction protocol (Hoffmann et al., 1987) and purified from 
electrophoresis gel by GE Healthcare Illustra GFX PCR DNA and Gel Band Purification kit (GE 
Healthcare, Buckinghamshire, UK). Five hundred ng of each purified plasmid was sequenced by 
BMR Genomics srl (Padova, IT). Results obtained were analyzed using BLAST algorithm and 
ClustalW (www.ebi.ac.uk/Tools/msa/clustalw2).  
 
Environmental Scanning Electron Microscopy (ESEM) analysis 
 
To shed light on the physical interactions and behavior of yeast cells and CdS QDs ESEM/EDX 
analyses were performed by environmental scanning electron microscope FEI Quanta 250FEG 
(FEI, Hillsboro, OR, USA). Yeast strains samples were prepared following Shen et al., 2011.  
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Statistical analysis 
 
Biorad Quantity One 4.2.0 software (Biorad, Hercules, CA, USA) was used to acquire and analyze 
each plate, both for the MIC estimation and the screening of the mutant collection. Statistics 
software SPSS 17.0 (http://www-01.ibm.com/software/it/analytics/spss/) was used for most of the 
statistics analyses. The positive results were scored when colony size in treated conditions were 
decreased (no growth or slow growth phenotype, in case of sensitivity) or increased (overgrowth 
phenotype, in case of resistance). All the results were normalized on wild type strain internal 
control (unaffected) and through the colony size of the corresponding strain growth on the control 
plate (untreated). Background correction was performed on the score of the empty well control for 
each plate. A two-sample t-test was used to evaluate the variations of the growth in each treatment 
(P < 0.01). Overgrowth or slow growth data corresponding to each mutant were analyzed using the 
Gene Ontology database (www.geneonthology.org/), DAVID Bioinformatic Database  ver. 6.7 
(http://david.abcc.ncifcrf.gov/; Huang et al., 2008) and FunSpec software 
(http://funspec.med.utoronto.ca/; Robinson et al., 2002). Network analyses was performed by 
GeneMANIA data service (www.genemania.org/; Mostafavi et al., 2008). 
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Results & Discussion 
 
Determination of the Minimal Inhibitory Concentration (MIC) 
 
MIC determination was performer on YPD, YPG and SC media.  
Concerning YPD, concentrations tested after 24h of incubation did not shown differences with the 
control untreated in cell growth before a concentration of  250 mg L
-1 
of CdS QDs. Conversely, 
cells grown under condition of treatment between 500 mg L
-1 
and 750 mg L
-1
 showed, compared 
with the control untreated, a significant reduction of the growth. Only the  concentration of 1000 mg 
L
-1
 led to the complete inhibition of the cell growth. Concentrations tested after 72h of growth, did 
not shown differences with the same treatments tested after 24 h of incubation, except in case of 
treatment with 250 mg L
-1
, in which the growth observed was less than the untreated control (Fig. 
21). This result suggested that the cellular intake of QDs could be physically hindered by the yeast 
cell wall (made of 1,3 β-glucan and other tight molecules). 
  
 
Figure 21. Plot representing growth of yeast cells on YPD medium supplemented with increasing concentration of CdS 
QDs, starting from 40 mg L
-1
 to 1000 mg L
-1
, after 24h (blue) and 72h (red) of incubation. Results reported were 
calculated on the differences between the control untreated and the yeast grown in treated conditions. 
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On YPG growth medium the minimum inhibitory concentration resulted lower than on YPD growth 
conditions. Cells grown on CdS QDs in a range between 40 mg L
-1 
to 200 mg L
-1 
did not shown any 
difference with the untreated control. Increasing the concentration over 200 mg L
-1 
yeast cell growth 
started to decrease rapidly, in particular after 72h (Fig. 22). The significant difference between MIC 
estimated in YPD and in YPG medium, treated with increasing concentrations of CdS QDs, may be 
due to carbon source exchange, from fermentable dextrose to non-fermentable glycerol, with effect 
in terms of adaptive lag to the non-fermentable growth conditions. It follows that the local 
concentration of CdS QDs at which the yeast cells were exposed result to be higher. There are no 
significant differences in treated and untreated conditions after 24h growth.  
       
 
Figure 22. Plot representing growth of yeast cells on YPG medium supplemented with increasing concentration of CdS 
QDs, starting from 40 mg L
-1
 to 500 mg L
-1
, after 24h (blue) and 72h (red) of incubation. Results reported were 
calculated on the differences between the control untreated and the yeast grown in treated conditions. 
 
On SC medium, supplemented with histidine, leucine, lysine and uracil, the effect of “local 
concentration” increase was much evident (Fig. 23), and the minimal inhibitory concentration 
decrease in all the treatments (estimated at 250 mg L
-1
). 
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Figure 23. Plot representing growth of yeast cells on Synthetic Complete medium supplemented with His, Lys, Leu, 
uracil and increasing concentration of CdS QDs, starting from 100 mg L
-1
 to 400 mg L
-1
, after 24h (blue) and 72h (red) 
of incubation. Results reported were calculated on the differences between the control untreated and the yeast grown in 
treated conditions. 
 
Assuming that the low intake of CdS QDs from the yeast cell was caused by a low permeability of 
the cell wall we decided to grew yeast cells on YPD supplemented with different concentrations of 
nystatin to increase the cell wall permeability and, consequently, the cellular intake of the QDs to 
study the internal molecular mechanisms in which the QDs could be involved. Starting with 0.1 mg 
L
-1
 to 0.4 mg L
-1
 of nystatin, effects on the cell growth, in condition of treatment with CdS QDs, 
were not significantly different from the growth on YPD supplemented with QDs only. Increasing 
the concentration of nystatin between 1 mg L
-1
 and 3.3 mg L
-1
 (representing the minimal inhibitory 
concentration of nystatin in S. cerevisiae) the toxic effect of the drug became preponderant 
compared to the effect of CdS QDs (data not shown). A concentration of 0.55 mg L
-1
, equal to 1/5 
of nystatin MIC in yeast, was evaluate as the more useful to assay the effect of CdS QDs on yeast 
growth. Results reported in figure 24 shown the trend of growth observed increasing the 
concentration of CdS QDs from 50 mg L
-1 
to 500 mg L
-1
. A minimal inhibitory concentration (MIC) 
of CdS QDs (200 mg L
-1
) was estimated. This concentration was used for the screening of yeast 
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Knock Out mutant collection. This concentration allowed also to drastically reduce the quantity of 
CdS QDs used in all the following steps.  
 
 
Figure 24. Plot representing growth of yeast cells on YPD medium supplemented with 0.55 mg L
-1 
and increasing 
concentration of CdS QDs, starting from 50 mg L
-1
 to 500 mg L
-1
, after 24h (blue) and 72h (red) of incubation. Results 
reported were calculated on the differences between the control untreated and the yeast grown in treated conditions. 
 
Screening of the knock out mutant collection 
 
Through the acquisition of values related to the levels of growth of the yeast Knock Out mutants  
collection and the statistical treatment of the data 220 yeast strains that showed a growth 
statistically different from the controls untreated were obtained: 109 mutants in which sensitivity 
was observed and 113 mutants that showed a resistant phenotype.  
Gene Ontology database provided, for each ORF related to the corresponding Knock Out mutant 
isolated, information concerning the gene encoded and the function in which the gene product was 
involved. Analysis provided by Funspec database (Appendix Tab.1, 2, 3, 4, 5, 6) concerning the 
genes corresponding to the mutant strains were subdivided in different clusters based on molecular 
functions and biological and cellular processes in which the genes were involved (P > 0.05).   
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Contrary to our expectations none of the genes exceeded the fixed threshold were related to 
ergosterol synthesis pathway. This result is probably due to the addition of nystatin that, through in 
sublethal concentrations for the wild-type, had on the mutants a preponderant effect compared to 
the CdS QDs.  
Data obtained from the screening were represented through heatmap pictures (Fig 25 a,b). In each 
heatmap were reported the growth levels of control untreated (control), treatment with nystatin 
(nist) and treatment with nystatin and CdS QDs (nist+QDs). The fourth lane “delta” (Δ) represents 
the difference of signal obtained from the subtraction of the nystatin background signal from the 
overall signal derived from treatment with CdS QDs and nystatin. The results obtained were 
normalized using the signal of the untreated control (in black). Growth signals lower than the 
control were reported in green whereas the growth signal higher than the control were reported in 
red.  
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Figure 25: Heatmaps representing the growth signal of the sensitive (a) and resistant (b) deleted yeast strains.  
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Through the SGD Gene Ontology Slim Mapper tool, it was possible to classify the ORFs whose 
deletion appears to be responsible for sensitive (Fig. 26) or resistant (Fig.27) phenotypes, according 
to the cellular process in which were involved the corresponding gene products. 
 
 
 
Figure 26. Pie chart of biological processes in which genes that conferring sensitive phenotype are involved. Results 
obtained from GO Slim Mapper tool. 
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Results obtained evidencing some of the genes involved in the response to stress: 4% of the genes 
whose deletion determined a sensitive phenotype were involved in mechanisms of abiotic stress 
response. Further 3% of the genes were involved in the response to DNA damage, a further 3 % in 
the mechanisms of DNA repair, and 2% in recombination events. Moreover 3 % of the genes are 
involved in ion transport, which could contribute to the detoxification by export and confinement 
within vesicles or organelles: one of the main detoxification mechanisms used by yeast is the 
internalization of xenobiotics within the vacuole, in order to decrease the cytosolic concentration 
below lethal values. In most cases, genes belong to generic response mechanisms, whereas some of 
the identified genes were already known as involved in Cd
2+
 ion specific response (Ypr133w-a, 
Ydr423c, Ydr140w, Ymr224c, Yil065c, Yil090c, Ymr275c, Ylr332w) (Ruotolo et al., 2008; 
Hillenmeyer et al., 2008). 
 
A list of sensitive genes includes some functions particularly interesting for our studies: cad1, also 
known as yap2, encodes for a leucine zipper transcriptional activator involved in response to stress, 
iron metabolism and the pleiotropic drug resistance. yap2 has a paralog called yap1. Although a 
sequence homology of 85%, the transcriptional activators encoded by the two genes are 
physiologically distinct. yap1 is involved in the response to various stress signals, such as hydrogen 
peroxide, thiol reagents and cadmium, whereas cad1 result not affected by these signals. However, 
it was observed how Cd
2+
 stimulates the transcriptional activation of cad1 promoting its 
accumulation within the nucleus. Furthermore, the insertion of cad1 gene inside a multicopy vector, 
allows the yeast cell to acquire cadmium resistance (Wu et al., 1993). Further studies have shown 
that the transcriptional activation of cad1 and yap1 is triggered by cadmium: in normal conditions  
(absence of stress), the two transcriptional activators are actively transported through the nuclear 
membrane by crm1 receptor. Cadmium activates the two transcriptional activators by binding of the 
crm1 c-terminal cystein rich domain, that masked the nuclear export signal (Azevedo et al., 2007).  
gcn4, encodes for another leucine zipper transcriptional activator. The activator gcn4 is regulated by 
a control system which increases its concentration within the cell in condition of lack of amino 
acids. gcn4 promotes the transcription of more than thirty genes involved in the aminoacids 
biosynthesis (Hinnenbusch et al., 2002).  
yap3, as cad1 and gcn4, encodes for a bZIP transcriptional activator. Unlike to the other two 
activators, yap3 is not involved either in response to cadmium, or in response to hydrogen peroxide. 
The deletion of yap3 gene, however, shows a decrease in the stress response (North et al., 2012) . 
mrpl44, encodes for a subunit of mitochondrial ribosomes; its concentration increases in response to 
stress in DNA replication (Graack et al., 1998) . 
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bul1, encodes for a protein involved in ubiquitination. It is a not essential component of E3- 
ubiquitin ligase complex, involved in the protein vacuolar sorting. bul1 has a functional homologue, 
bul2, with which is involved in Gap1p permease outbound and the activation of the gln3 
transcription factor, under nitrogen deficiency conditions. Furthermore, the deletion of bul1 leads to 
a decrease in the level of resistance to cadmium chloride (Serero et al., 2008). dsk2, encodes for 
another gene product involved in the ubiquitination process. It is overexpressed in response to stress 
in DNA replication (Dziedzic et al., 2011); its deletion leads to a reduced resistance to heavy metals 
stress. There are also other gene products involved in ubiquitination process:  rub1, qcr10, rkr1, 
siz1 and cue1. Ubiquitin/proteosome system is a part of the mechanisms responsible for maintaining 
protein homeostasis, and is the main pathway of protein degradation in cytoplasm and nucleus of 
eukaryotic cells. Ubiquitin overexpression lead up to increased resistance to several biotic and 
abiotic stresses (Chen et al., 1995), promoting the degradation of damaged proteins and protein 
aggregates. 
mid2, which encodes for a protein localized on cell wall membrane that acts as a sensor for stress-
induced remodeling of the cell wall during the growth stage. This protein is required, together with  
wsc1p, for the activation of the signaling pathway of the integrity of the wall. mid2 deleted strain 
show a sensitive phenotype to treatment with cadmium chloride (Gardarin et al., 2010).  
Concerning metabolic functions of mitochondrial genes several were found: tom5, which encodes a 
component of the TOM (Transporter Outer Membrane) complex, involved in the import of all the 
proteins directed to the mitochondrion; yhm2, encoding an active citrate/oxoglutarate antiport 
carrier in mitochondria which exploit NADPH; fis1, which encodes for a protein involved in the 
fission of the mitochondrial membrane, required for localization of dnm1p and mdv1p (proteins 
required for the remodeling of membranes) during mitochondrial division (Karren et al., 2005). 
Moving in this direction it is possible to conclude that mitochondria could be a possible target of 
CdS QDs, or in general QDs, thus influencing the redox balance of the cell (Li et al., 2011).   
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Figure 27. Pie chart of biological processes in which genes that conferring resistant phenotype are involved. Results 
obtained from GO Slim Mapper tool. 
 
Among the mutants in which deleted genes produce a resistant phenotypes, genes were identified 
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studies: vac7, which encodes for a membrane protein involved in vacuolar morphology and 
vacuolar inheritance. The mutants deleted in vac7 have a vacuoles size greatly increased, able to 
grow at high temperatures. vac7 determine the activity of phosphatidylinositol 3-phosphate 5-kinase 
Fab1 in conditions of hyperosmotic shock (Gary et al., 2002).  
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vtc2, encodes a for subunit of the vacuolar transport chaperone complex, is involved in membrane 
trafficking, accumulation of polyphosphates in vacuoles and, in the non-autophagic vacuolar fusion 
(Uttenweiler et al., 2007); 
vma4, encodes for the subunit E of V1 domain of H
+
-vacuolar ATPase. It is an ATP-dependent 
proton pump involved in the acidification of vacuolar compartments, essential for several processes 
including endocytosis and targeting of lysosomal enzymes synthesized. The cell concentration of 
this protein increases in stress response of DNA replication (Tkach et al., 2012). 
It is also present yol092w gene, which is noted as encoding a putative vacuolar transporter for 
cationic aminoacids. 
Some of the candidate genes coincide or are closely related to those involved in mechanisms of 
resistance to gold nanoparticles (Smith et al., 2013): for example, trk1 is a component of the K
+
 
transport system Trk1p-Trk2p. Its deletion increased the phenotype of resistance to hydrogen 
peroxide and heavy metals. In particular it has been postulated that gold nanoparticles with a size of 
0.8 nm, interact with the complex Trk1p-Trk2p allowing the leakage from the cell of cytoplasmic 
constituents, such as ATP and K
+
. 
sus1 and hfi1 are components of the SAGA (Spt-Ada-Gcn5-Acetyltransferase) complex involved in 
histones acetylation. Gene Ontology analysis revealed that the majority of genes reported in Smith 
et al., 2013 has mitochondrial localization, and their deletion lead consequently a cellular 
respiration deficiency. 
Hierarchical clustering analysis of the data obtained through FunSpec database, highlighted the 
presence  of genes (5%), involved in the organization of the mitochondrion whose deletion showed 
a resistant phenotype. These genes encode for: i) proteins of the inner membrane, ii) proteins 
involved in metabolic reactions, iii) proteins involved in transcription and translation processes. 
mos1 and mos2, are essential for the organization of the inner membrane. som1, encodes a subunit 
of a peptidase required for proteins processing in the intermembrane space. phb2, encodes a subunit 
for a chaperone complex that stabilizes proteins and is also involved in the segregation of 
mitochondria. hmi1, encode for a ATP-dependent helicase necessary for the maintenance of the 
genome mitochondrial. por2, encodes a porin that is a component of a voltage-dependent anion 
channel. Among the genes involved in metabolic processes, is reported pdb1, which encodes for a 
subunit of the pyruvate dehydrogenase complex, ups2 and pim1, that encode for proteins involved 
respectively in the metabolism of phospholipids and proteins.  
In addition to Gene Ontology data, it was possible to identify pathways in which genes appear to be 
involved in the list of sensitive mutants, in particular metabolism of phenylalanine and the 
metabolism of xenobiotics. In both pathways has been found the presence of genes ald2 and ald3, 
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encoding two different cytoplasmic aldehyde dehydrogenase, whose sequences showed a similarity 
of 92%. These genes are induced in the presence of different types of stress : in particular, ald2 is 
induced by osmotic stress and low glucose levels , while ald3 is induced by osmotic stress , heat 
stress, oxidative stress, chemical compounds and lack of glucose (Navarro-Aviño et al., 1999). 
Furthermore, within the pathway of the metabolism of phenylalanine, the gene: aro10 , coding for a 
phenylpyruvate decarboxylase, that catalyzes the conversion of phenylpyruvate in 
phenylacetaldehyde.  
Concerning genes whose deletion confers a phenotype resistant to treatment, none was recognized 
as  involved in any metabolic pathways. 
The two lists of candidate genes were analyzed separately through GeneMANIA software, which 
uses a wide range of functional correlation data to highlight the presence of interactions between 
genes of interest and identifies other genes related to them. These interactions can be displayed in 
the form of a network of interactions, built using a heuristic algorithm derived from the Pearson 
correlation. Regarding the genes whose deletion determines a sensitive phenotype, were identified 
two main networks. The first, shown in figure 28, contains the genes involved in the mechanism of 
response to stress, among which we can easily identify cad1, involved in resistance to the ion 
cadmium , and other genes that have been discussed previously (gcn4, dsk2, rub1, cue1). One of the 
main interactors within our query is hsc82 which appears to be positioned in the center of the 
network of interaction: it belong to the family of cytoplasmic chaperone hsp90 , involved in the 
mechanisms of heat shock response and DNA stress. hsc82p has a paralog, hsp82, which functions 
almost identically and originated following the duplication of the entire genome. hsc82 is 
constitutively expressed at levels ten times higher than the paralog, also indicated in the interaction 
network. 
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Figure 28: Network of sensitive genes which involved stress response.   
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Figure 29: Network of sensitive genes which involved biosynthetic processes.   
 
 
The second network contains biosynthetic genes, including ald2, ald3 and aro10 previously 
identified also through the analysis of gene ontology as components of the phenylalanine pathway 
(Fig.29).  
Regarding the genes whose deletion produced a resistant phenotype, has been identified a single 
network (Fig. 30). In the all the network generated, it is identified the presence of genes not yet 
characterized. The data collected, once confirmed, could therefore help to provide information 
useful in defining the role of these genes in the yeast genome. 
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Figure 30: Network of resistant genes which involved stress response.   
 
 
 
 
 
67 
 
The cadmium salt comparison 
 
The comparison of the results obtained with data already available becomes necessary. In fact, a 
direct comparison with the genes of S. cerevisiae involved in Cd response
 
showed a narrow overlap 
with our results. Genes ypr133w-a, ydr423c, ydr140w, ymr224c, yil065c, yil090c and ymr275c, 
classified as low-sensitive and medium-sensitive to Cd ion treatment (Ruotolo et al., 2008; 
Hillenmeyer et al., 2008), are the only genes in common with our results. Also between the genes 
mentioned as susceptible to treatment with CdCl2, appeared to be present in our list of sensitive 
mutants to CdS QDs, specifically mid2 and cad1 genes. The weak overlap between the two 
responses could evidence how the mechanisms of resistance to Cd ions and to CdS QDs are 
different and the effect of treatment with CdS QDs could not merely be ascribed to the effect of Cd. 
This result supports our previous hypothesis concerning the mechanisms involved in CdS QDs 
response in Arabidopsis thaliana.  
 
Spot assay 
 
From the list of genes whose deletion causes a sensitive phenotype to CdS QDs treatment, were 
selected some mutants, which were subjected to confirmation of phenotype changed by spot assay. 
Wild type strain BY4742 was used as positive control. This test provides a general indication of the 
level of sensitivity of the various mutants to treatments, based on the last dilution in which growth 
was observed . 
After 48 hours of growth it was possible to identify sensitive phenotypes in the mutants screened 
and this result confirmed the screening mentioned above.  
Particularly, focusing the attention on Δcue1 and Δcst6 mutants, they showed an higher level of 
sensitivity than the other mutant analyzed. Growth, for these two mutants, appears to be already 
inhibited at concentrations of 10
5
 cells/ml (Fig. 31). For the mutants Δrkr1, Δvps62, Δzap3, Δshu1 
and Δmid2, growth is inhibited at concentrations of 104 cells/ml. For the mutants Δrgm1, Δhsc82, 
Δdsk2, Δyku70, Δspt3, Δbul1 and Δsiz1 was observed a very limited growth in concentrations of 104 
cells/ml, at levels lower than the positive control present in each plate.  
Mutants tested, along with the others present in the gene list whose mutation causes a sensitive 
phenotype, were validated by transformation with centromeric and multicopy plasmids containing 
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the deleted genes. This approach allows to obtain, through their phenotypes, information about 
genes with a key role in the response to CdS QDs.  
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Figure 31: Spot assay of the mutants in genes whose deletions showed a sensitive phenotype to CdS QDs. In the first 
lane (YPD) mutants and wild type strains were grown without treatment; in the second lane (YPD+nystatin) mutants 
and wild type strains were grown on nystatin (0,55 mg L
-1
); in the third lane mutants and wild type strains were grown 
YPD supplemented with nystatin (0,55 mg L
-1
) and CdS QDs (200 mg L
-1
). 
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Rescue of the phenotype by complementation 
 
Through the complementation of the phenotype, using two genomic library inserted in the  
centromeric and multicopy vectors, some transformed colonies were observed and isolated. These 
colonies showed on the SC-URA supplemented medium a growth not statistically different from the 
control (not supplemented). To facilitate the isolation of possible revertant strains the sensitive 
mutants were subdivided in 12 pools. Description of the 12 pools of mutants is reported in 
Appendix Table 7. In the first round of screening revertant phenotypes were observed in pool 9. A 
second round of transformation and screening on nystatin and CdS QDs was performed only on the 
single strain isolated from the pool. Only for the mutant Δhsc82, the revertant phenotype was 
evidenced. To confirm the revertant phenotype a spot assay was performed (Fig.32).  
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Figure 32: Spot assay of Δhsc82 mutant. In the first lane (SC-URA) transformed wild type and Δhsc82 strains were 
grown without treatment; in the second lane (SC-URA+nystatin) transformed strains were grown on nystatin (0,55 mg 
L
-1
); in the third lane transformed strains were grown on SC(-URA) supplemented with nystatin (0,55 mg L
-1
) and CdS 
QDs (200 mg L
-1
). 
 
The analysis of the wild type+pRS416 (empty plasmid) was used as positive control for the growth 
of the wild type on SC-URA medium. Since the wild type strain does not carry the ura3 gene and 
the non-transformed strain would not be able to grow on SC medium without uracil. Transformed 
mutants Δhsc82 with the empty plasmid was used as a negative control for growth. On medium 
containing nystatin it was observed, as expected, the growth of yeast strains in all dilutions because 
the sub-lethal concentration of nystatin used acts only to increase the permeability of the cell wall. 
On medium containing nystatin and CdS QDs growth of the complemented mutant was not 
significantly different from the growth of the wild-type. This result constitutes the proof  that the 
fragment inserted into the centromeric vector rescued the mutation. 
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The sequence contained in plasmids sequenced was recognized by BLAST (E-value = 0.0, Identity 
= 99%) as the upstream region of the gene encoding the heat shock protein of Saccharomyces 
cerevisiae hsc82. This confirmed the complementation of the deleted mutant Δhsc82. 
This result highlighted the importance of this gene in the response to stress inducted by CdS QDs. 
The key role of hsc82 gene at this point becomes fundamental in the response to CdS QDs and as 
previously seen in the network of sensitive genes (Fig. 28) the heat shock protein is recognized as 
one of the hub of the interaction network. It is not possible to identify this gene as the main 
character of the resistance but the phenotype of  hsc82 is undoubtedly epistatic in respect of the 
other genes. This phenomenon becomes evident when the condition of growth, due to the change of 
growth medium necessary for the selection of transformed yeast strains, are more restrictive and the 
time to develop the growing colony is higher. Certainly hsc82 is not an arrival point, but rather a 
starting point on which to build future experiments. 
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Environmental Scanning Electron Microscopy (ESEM) analysis 
 
For the first time we were able to analyzed the interactions between nano-aggregates of CdS QDs 
and yeast cells (Fig. 33). This could suggest finally how the cells physically interact with the 
nanomaterials.  
 
 
Figure 33: nanomaterials analyzed with ESEM/EDX. CdS QDs aggregates (A). Nanomaterials aggregates interactions 
with yeast cells (B). Scale and ESEM parameters are showed below.  
 
The microanalysis conducted to highlight the elements (data not shown) showed the presence of 
only the elements cadmium (Cd) and sulfur (S) in equal proportions. The individual particles are 
found to be of a diameter not exceeding 20 nm. These findings certify the successful identification 
of the CdS QDs. Microanalysis conducted on cells has not provided yet significant results on the 
presence or absence of the nanoparticles within the cells since the cell wall, together with the 
treatment performed, do not allow to obtain the expected result. 
This result do not clarify the mechanism of internalization and also which could be the physico-
chemical form of CdS QDs is internalized in the cell. Further analyses will be performed to 
elucidate this point, both for yeast and plants.  
 
 
A B 
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Conclusions 
 
Concluding, two A. thaliana mutants, atnp01 e atnp02 resistant to CdS QDs were isolated. 
Through the AAS analysis we found that mutants and wild type showed a same level of Cd
2+
 
uptake whereas atnp01 e atnp02 resulted to be more tolerant than the wild type in condition of CdS 
QDs treatment. Physiological parameters highlighted that mutant lines are tolerant to CdS QDs, not 
CdSO4. Genetic backcrosses clarified the stability of the mutant lines, ensured by the absence of 
transposition. 
Microarray analyses and Real Time PCR confirmed how our mutant lines can be an instrument for 
the understanding of the CdS QDs tolerance/resistance mechanisms and the key genes involved. 
At1g13880 (ELM2, putative MYB transcriptional activator) could offer a possible explanation of 
the mechanisms of stress response involved in tolerance/resistance to CdS QDs. Furthermore, the 
comparison with cadmium ion stress response, confirmed by Real Time PCR and physiological 
parameters analyzed, has shown that Cd
2+
 and CdS QDs exploit different pathways of 
tolerance/resistance. 
Analyses performed on yeast may suggest a similar response both for plant and fungi. The 
combination of the results obtained in plant and in yeast could offer a possible  hypothesis for the 
torelance/resitance mechanism in which the CdS QDs are involved. Similarly to A. thaliana, also in 
case of S. cerevisiae, the results found suggested how the CdS QDs and the Cd
2+
 could exploit 
different pathways of tolerance/resistance. It was observed a possible epistatic activity by which the 
up- or down-regulation of one or few genes (At1g13880 in plant or hsc82 in yeast) could lead to a 
cascade of other genes regulated during the CdS QDs response, both in yeast and plants.  
Results obtained from this study could add information about the possible mechanisms exploited 
by CdS QDs and the potential risk attributable to the Cd-based QDs, and NMs in general. The use 
of model organisms, as A. thaliana or S. cerevisiase, could offer safe strategies for the risk 
assessment of  NMs concerning environment and health. Therefore, plant-based model systems are 
able to provide information about plant-specific targets and could be also useful to investigate 
targets of more general interest in more complex organisms, such as animals, about the risks posed 
by the exposition and contact with NMs. Our approach, which merge the classical top-down 
approach (the isolation of the resistant mutants)  and the bottom-up approach (transcriptomic and 
proteomic experiments), allows to shed light on function and functionality of our targets: from 
observing phenotype to knowing what lays genetically behind that phenotype.    
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Future Perspectives 
 
There are many possibility and many aspects that we would study in deep. First of all, our future 
studies will be direct to define pathways and networks of interactions relating the CdS QDs 
tolerance/resistance mechanisms and understand also the conservation of CdS QDs tolerance 
mechanisms in other organisms, phylogenetically near and far, from human cells, many organisms 
along the food chain, from Daphnia magna  to zebrafish (Danio rerio). Also other higher plants can 
become the target of this type of study.  
The definition of specific target, both in yeast and plants, will open to new possibility for 
understanding what lays genetically behind the phenomenon of CdS QDs tolerance/resistance. 
Utilizing complementation on yeast by heterologous expression of  A. thaliana genes (and vice 
versa), we will be able to clarify the importance of the candidates genes isolated in our studies.  
Proteomic analysis on A. thaliana mutants are in still in progress. Total protein extracts were 
already separated by ProteomeLab PF2D platform. The results will be processed to highlight the 
differences between wild type and mutants in treated (80 mg L
-1
 of CdS QDs) and untreated 
conditions. Furthermore results must be implemented with the characterization of the peptides 
identified by MS-MS fingerprinting. 
In order to find out information about localization of CdS QDs within cells and plant tissues, we 
will also perform analyses using environmental scanning microanalysis (ESEM/EDX).   
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Appendix 
 
Table 1: GO Molecular Function - sensitive mutants  
Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
protein dimerization activity [GO:0046983] 0.0002978 
CAD1 GCN4 
YAP3 CST6  
4 20 
carboxylesterase activity [GO:0004091] 0.0009108 
YJL068C 
YLR118C 
YMR210W  
3 12 
aldehyde dehydrogenase (NAD) activity 
[GO:0004029] 
0.00271 ALD3 ALD2  2 5 
transmembrane receptor activity [GO:0004888] 0.00271 WSC4 MID2  2 5 
carboxy-lyase activity [GO:0016831] 0.003139 
ARO10 YEL020C 
GAD1  
3 18 
aldehyde dehydrogenase [NAD(P)+] activity 
[GO:0004030] 
0.00402 ALD3 ALD2  2 6 
oxidoreductase activity, acting on the aldehyde or 
oxo group of donors, NAD or NADP as acceptor 
[GO:0016620] 
0.005566 TDH3 YMR226C  2 7 
thiamine pyrophosphate binding [GO:0030976] 0.00734 ARO10 YEL020C  2 8 
RNA polymerase II transcription factor activity 
[GO:0003702] 
0.008124 
SPT3 CAD1 
RGM1  
3 25 
phenylpyruvate decarboxylase activity 
[GO:0050177] 
0.01681 ARO10  1 1 
protein C-terminal S-isoprenylcysteine carboxyl 
O-methyltransferase activity [GO:0004671] 
0.01681 STE14  1 1 
glutamate decarboxylase activity [GO:0004351] 0.01681 GAD1  1 1 
histone methyltransferase activity (H3-K79 
specific) [GO:0031151] 
0.01681 DOT1  1 1 
ubiquitin-protein ligase activator activity 
[GO:0097027] 
0.01681 CUE1  1 1 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
palmitoyl-(protein) hydrolase activity 
[GO:0008474] 
0.01681 YLR118C  1 1 
peroxisome matrix targeting signal-2 binding 
[GO:0005053] 
0.01681 PEX7  1 1 
S-formylglutathione hydrolase activity 
[GO:0018738] 
0.01681 YJL068C  1 1 
[cytochrome c]-lysine N-methyltransferase 
activity [GO:0000277] 
0.01681 CTM1  1 1 
mRNA 3'-UTR binding [GO:0003730] 0.01681 PUF6  1 1 
methyltransferase activity [GO:0008168] 0.03108 
MTQ2 STE14 
DOT1 CTM1  
4 71 
translation repressor activity, nucleic acid binding 
[GO:0000900] 
0.03334 PUF6  1 2 
tricarboxylate secondary active transmembrane 
transporter activity [GO:0005371] 
0.03334 YHM2  1 2 
arylformamidase activity [GO:0004061] 0.03334 BNA7  1 2 
D-arabinose 1-dehydrogenase [NAD(P)+] activity 
[GO:0045290] 
0.03334 ARA1  1 2 
2-deoxyglucose-6-phosphatase activity 
[GO:0003850] 
0.03334 DOG1  1 2 
nucleosomal histone binding [GO:0031493] 0.03334 DOT1  1 2 
GTPase inhibitor activity [GO:0005095] 0.03334 ROY1  1 2 
UTP:glucose-1-phosphate uridylyltransferase 
activity [GO:0003983] 
0.03334 YHL012W  1 2 
chaperone binding [GO:0051087] 0.03976 CAJ1 SCJ1  2 19 
lyase activity [GO:0016829] 0.04345 
ARO10 YEL020C 
YHR112C GAD1  
4 79 
damaged DNA binding [GO:0003684] 0.0437 RAD14 YKU70  2 20 
metalloendopeptidase activity [GO:0004222] 0.04778 CYM1 RCE1  2 21 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
glyceraldehyde-3-phosphate dehydrogenase 
activity [GO:0008943] 
0.0496 TDH3  1 3 
glyceraldehyde-3-phosphate dehydrogenase 
(NAD+) (phosphorylating) activity [GO:0004365] 
0.0496 TDH3  1 3 
cystathionine beta-lyase activity [GO:0004121] 0.0496 YHR112C  1 3 
NAD+ kinase activity [GO:0003951] 0.0496 YEF1  1 3 
NADH kinase activity [GO:0042736] 0.0496 YEF1  1 3 
histone-lysine N-methyltransferase activity 
[GO:0018024] 
0.0496 DOT1  1 3 
G-quadruplex DNA binding [GO:0051880] 0.0496 MRE11  1 3 
ATPase activity, coupled [GO:0042623] 0.0496 HSC82  1 3 
double-stranded telomeric DNA binding 
[GO:0003691] 
0.0496 MRE11  1 3 
trehalose-phosphatase activity [GO:0004805] 0.0496 TPS3  1 3 
1-acylglycerol-3-phosphate O-acyltransferase 
activity [GO:0003841] 
0.0496 SLC1  1 3 
alpha,alpha-trehalose-phosphate synthase (UDP-
forming) activity [GO:0003825] 
0.0496 TPS3  1 3 
nuclear localization sequence binding 
[GO:0008139] 
0.0496 ETP1  1 3 
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Table 2: GO Biological Process - sensitive mutants 
Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
beta-alanine biosynthetic process [GO:0019483] 0.0002801 ALD3 ALD2  2 2 
polyamine catabolic process [GO:0006598] 0.000831 ALD3 ALD2  2 3 
ER-associated protein catabolic process 
[GO:0030433] 
0.001181 
DFM1 ADD37 SCJ1 
CUE1 DSK2  
5 48 
tryptophan catabolic process [GO:0006569] 0.005566 ARO10 BNA7  2 7 
peptide pheromone maturation [GO:0007323] 0.00734 STE14 RCE1  2 8 
meiotic DNA double-strand break formation 
[GO:0042138] 
0.01154 REC102 MRE11  2 10 
recombinational repair [GO:0000725] 0.01154 DOT1 SHU1  2 10 
negative regulation of GTPase activity 
[GO:0034260] 
0.01681 ROY1  1 1 
glutamate catabolic process [GO:0006538] 0.01681 GAD1  1 1 
methionine catabolic process to 3-
methylthiopropanol [GO:0000951] 
0.01681 ARO10  1 1 
protein deacylation [GO:0035601] 0.01681 YLR118C  1 1 
establishment of protein localization in 
endoplasmic reticulum membrane 
[GO:0097051] 
0.01681 CUE1  1 1 
glutamate metabolic process [GO:0006536] 0.01681 GAD1  1 1 
cellular response to oleic acid [GO:0071400] 0.01681 CST6  1 1 
peptidyl-lysine methylation [GO:0018022] 0.01681 CTM1  1 1 
alpha-ketoglutarate transport [GO:0015742] 0.01681 YHM2  1 1 
tricarboxylic acid transport [GO:0006842] 0.01681 YHM2  1 1 
regulation of transcription during meiosis 
[GO:0051037] 
0.01681 MRE11  1 1 
DNA metabolic process [GO:0006259] 0.01936 CST6 MRE11  2 13 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
endoplasmic reticulum unfolded protein 
response [GO:0030968] 
0.01936 DFM1 YHI9  2 13 
methylation [GO:0032259] 0.03108 
MTQ2 STE14 
DOT1 CTM1  
4 71 
tyrosine catabolic process [GO:0006572] 0.03334 ARO10  1 2 
negative regulation of ribosomal protein gene 
transcription from RNA polymerase II promoter 
[GO:0010688] 
0.03334 CRF1  1 2 
C-terminal protein methylation [GO:0006481] 0.03334 STE14  1 2 
long-chain fatty-acyl-CoA metabolic process 
[GO:0035336] 
0.03334 FAA4  1 2 
positive regulation of transcription initiation 
from RNA polymerase II promoter 
[GO:0060261] 
0.03334 GCN4  1 2 
peptidyl-glutamine methylation [GO:0018364] 0.03334 MTQ2  1 2 
chloride transport [GO:0006821] 0.03334 YHL008C  1 2 
monocarboxylic acid transport [GO:0015718] 0.03334 YHL008C  1 2 
response to ethanol [GO:0045471] 0.03334 ETP1  1 2 
cell morphogenesis involved in conjugation 
[GO:0000767] 
0.03334 MID2  1 2 
formaldehyde catabolic process [GO:0046294] 0.03334 YJL068C  1 2 
CAAX-box protein processing [GO:0071586] 0.03334 RCE1  1 2 
branched chain family amino acid catabolic 
process to alcohol via Ehrlich pathway 
[GO:0000950] 
0.03334 ARO10  1 2 
glycerophospholipid biosynthetic process 
[GO:0046474] 
0.03334 SLC1  1 2 
mitochondrial citrate transport [GO:0006843] 0.03334 YHM2  1 2 
response to stress [GO:0006950] 0.04238 
DFM1 RTA1 WSC4 
MID2 HSC82 TPS3  
6 152 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in 
category 
Number of 
genes in 
category 
chromatin modification [GO:0016568] 0.04249 
SPT3 DOT1 VPS72 
EAF5 RKR1  
5 114 
endocytosis [GO:0006897] 0.04871 
DNF1 BZZ1 GVP36 
ROY1  
4 82 
NADP biosynthetic process [GO:0006741] 0.0496 YEF1  1 3 
histone lysine methylation [GO:0034968] 0.0496 DOT1  1 3 
leucine catabolic process [GO:0006552] 0.0496 ARO10  1 3 
medium-chain fatty acid biosynthetic process 
[GO:0051792] 
0.0496 YMR210W  1 3 
global genome nucleotide-excision repair 
[GO:0070911] 
0.0496 DOT1  1 3 
cell cycle arrest [GO:0007050] 0.0496 HUG1  1 3 
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Table 3: GO Cellular Component - sensitive mutants 
Category p-value 
In Category 
from Cluster 
Number of genes 
observed in category 
Number of genes 
in category 
lipid particle [GO:0005811] 0.003955 
CST26 SLC1 
TDH3 FAA4  
4 39 
Doa10p ubiquitin ligase complex 
[GO:0000837] 
0.00402 DFM1 CUE1  2 6 
nuclear inner membrane [GO:0005637] 0.01395 STE14 HEH2  2 11 
DNA-dependent protein kinase-DNA 
ligase 4 complex [GO:0005958] 
0.01681 YKU70  1 1 
endoplasmic reticulum lumen 
[GO:0005788] 
0.02234 EUG1 SCJ1  2 14 
peroxisome [GO:0005777] 0.02456 
PEX7 PEX29 
GTO1 FIS1  
4 66 
integral to endoplasmic reticulum 
membrane [GO:0030176] 
0.02726 
ICE2 CUE1 
RCE1  
3 39 
integral to nuclear inner membrane 
[GO:0005639] 
0.03334 HEH2  1 2 
cellular bud scar [GO:0005621] 0.03334 RAX2  1 2 
Ku70:Ku80 complex [GO:0043564] 0.03334 YKU70  1 2 
eRF1 methyltransferase complex 
[GO:0035657] 
0.03334 MTQ2  1 2 
nucleotide-excision repair factor 1 complex 
[GO:0000110] 
0.0496 RAD14  1 3 
Mre11 complex [GO:0030870] 0.0496 MRE11  1 3 
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Table 4: GO Molecular Function - resistant mutants 
Category p-value In Category from Cluster 
Number of 
genes 
observed in 
category 
Number 
of genes in 
category 
transcription coactivator 
activity [GO:0003713] 
0.004172 SWI6 SIN3 HFI1  3 20 
molecular_function 
[GO:0003674] 
0.008453 
MOH1 PIN4 YBR196C-A YBR196C-B YBR200W-A 
YBR221W-A YBR296C-A YCL001W-B YCL057C-A 
YDL159W-A YDR003W-A YDR034W-B YDR169C-
A YDR246W-A DYN2 YER053C-A YER077C VTC2 
YFR012W-A YGL006W-A YGL041C-B YGL188C-A 
YGR204C-A PHB2 YGR235C YHR050W-A 
YIL108W SIM1 YIR018C-A YJL127C-B YJL144W 
IDS2 YJL147C YKL068W-A YKL106C-A UPS2 
VAC7 YNL115C YOL092W YOL098C BSC6 RTC1 
RSA1 THP3 MCM16  
45 1973 
serine-type endopeptidase 
activity [GO:0004252] 
0.01134 PIM1 NMA111  2 10 
ribonuclease T2 activity 
[GO:0033897] 
0.01666 RNY1  1 1 
ornithine 
carbamoyltransferase 
activity [GO:0004585] 
0.01666 ARG3  1 1 
glucan 1,4-alpha-
glucosidase activity 
[GO:0004339] 
0.01666 SGA1  1 1 
serine-type peptidase 
activity [GO:0008236] 
0.01903 PIM1 NMA111  2 13 
ubiquitin binding 
[GO:0043130] 
0.02318 SLA1 EDE1 BUB3  3 37 
pyruvate dehydrogenase 
(acetyl-transferring) 
activity [GO:0004739] 
0.03304 PDB1  1 2 
double-strand/single-
strand DNA junction 
binding [GO:0000406] 
0.03304 MSH2  1 2 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in category 
Number of genes 
in category 
sphingosine-1-phosphate phosphatase 
activity [GO:0042392] 
0.03304 LCB3  1 2 
single base insertion or deletion binding 
[GO:0032138] 
0.03304 MSH2  1 2 
potassium ion transmembrane transporter 
activity [GO:0015079] 
0.03304 TRK1  1 2 
carboxyl- or carbamoyltransferase activity 
[GO:0016743] 
0.03304 ARG3  1 2 
tyrosine-tRNA ligase activity 
[GO:0004831] 
0.03304 MSY1  1 2 
6-phosphofructokinase activity 
[GO:0003872] 
0.03304 PFK1  1 2 
tRNA (guanine-N1-)-methyltransferase 
activity [GO:0009019] 
0.03304 TRM10  1 2 
protein phosphatase regulator activity 
[GO:0019888] 
0.03304 PSY4  1 2 
ATP-dependent peptidase activity 
[GO:0004176] 
0.03304 PIM1  1 2 
metalloendopeptidase activity 
[GO:0004222] 
0.04701 COR1 YOL098C  2 21 
voltage-gated anion channel activity 
[GO:0008308] 
0.04916 POR2  1 3 
porin activity [GO:0015288] 0.04916 POR2  1 3 
1,3-beta-D-glucan synthase activity 
[GO:0003843] 
0.04916 FKS1  1 3 
guanine/thymine mispair binding 
[GO:0032137] 
0.04916 MSH2  1 3 
tRNA (guanine) methyltransferase activity 
[GO:0016423] 
0.04916 TRM10  1 3 
Y-form DNA binding [GO:0000403] 0.04916 MSH2  1 3 
 
 
92 
 
Table 5: GO Biological Process - resistant mutants 
Category p-value In Category from Cluster 
Number of 
genes 
observed in 
category 
Number 
of genes in 
category 
biological_process 
[GO:0008150] 
0.0008038 
MOH1 YBR196C-A YBR196C-B YBR200W-A 
YBR221W-A YBR296C-A YCL001W-B 
YCL057C-A YDL159W-A YDR003W-A 
YDR034W-B YDR169C-A YDR246W-A 
YER053C-A YER077C YFR012W-A 
YGL006W-A YGL041C-B YGL188C-A 
YGR204C-A YGR235C YHR050W-A YIL108W 
YIR018C-A YJL127C-B YJL147C YKL068W-A 
YKL106C-A APJ1 YNL115C YOL092W 
YOL098C BSC6 RTC1  
34 1203 
proteolysis [GO:0006508] 0.001377 PIM1 COR1 SOM1 NMA111 YOL098C YGK3  6 74 
cellular chaperone-mediated 
protein complex assembly 
[GO:0034619] 
0.01666 PIM1  1 1 
mitochondrial tyrosyl-tRNA 
aminoacylation [GO:0070184] 
0.01666 MSY1  1 1 
mitochondrial DNA metabolic 
process [GO:0032042] 
0.01666 HMI1  1 1 
histone modification 
[GO:0016570] 
0.01666 RTF1  1 1 
phosphatidylethanolamine 
metabolic process 
[GO:0046337] 
0.01666 UPS2  1 1 
translational readthrough 
[GO:0006451] 
0.01666 MTQ1  1 1 
polysaccharide metabolic 
process [GO:0005976] 
0.01666 SGA1  1 1 
error-free postreplication 
DNA repair [GO:0042275] 
0.03304 RAD18  1 2 
positive regulation of kinase 
activity [GO:0033674] 
0.03304 VAC7  1 2 
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Category p-value 
In Category 
from Cluster 
Number of genes 
observed in category 
Number of genes 
in category 
negative regulation of cAMP biosynthetic 
process [GO:0030818] 
0.03304 IRA2  1 2 
ornithine metabolic process [GO:0006591] 0.03304 ARG3  1 2 
negative regulation of transcription during 
meiosis [GO:0051038] 
0.03304 SIN3  1 2 
negative regulation of proteolysis [GO:0045861] 0.03304 PHB2  1 2 
DNA transport [GO:0051027] 0.03304 POR2  1 2 
tyrosyl-tRNA aminoacylation [GO:0006437] 0.03304 MSY1  1 2 
transcription from RNA polymerase II promoter 
[GO:0006366] 
0.03444 
RTF1 GAL11 
TAF14 HFI1  
4 74 
endocytosis [GO:0006897] 0.04738 
SLA1 EDE1 
SAC6 TLG2  
4 82 
regulation of anion transport [GO:0044070] 0.04916 POR2  1 3 
glycogen catabolic process [GO:0005980] 0.04916 SGA1  1 3 
N-terminal peptidyl-methionine acetylation 
[GO:0017196] 
0.04916 MDM20  1 3 
regulation of transcription involved in G2/M-
phase of mitotic cell cycle [GO:0000117] 
0.04916 SIN3  1 3 
meiotic gene conversion [GO:0006311] 0.04916 MSH2  1 3 
actin filament-based process [GO:0030029] 0.04916 DYN2  1 3 
mannosyl-inositol phosphorylceramide 
metabolic process [GO:0006675] 
0.04916 TLG2  1 3 
negative regulation of chromatin silencing at 
silent mating-type cassette [GO:0061186] 
0.04916 SIN3  1 3 
negative regulation of chromatin silencing at 
rDNA [GO:0061188] 
0.04916 SIN3  1 3 
histone monoubiquitination [GO:0010390] 0.04916 RTF1  1 3 
positive regulation of Ras GTPase activity 
[GO:0032320] 
0.04916 IRA2  1 3 
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Category p-value 
In Category 
from Cluster 
Number of genes 
observed in category 
Number of genes 
in category 
protein methylation [GO:0006479] 0.04916 MTQ1  1 3 
positive regulation of phosphatidylinositol 
biosynthetic process [GO:0010513] 
0.04916 VAC7  1 3 
negative regulation of DNA damage checkpoint 
[GO:2000002] 
0.04916 PSY4  1 3 
 
 
Table 6: GO Cellular Component – resistant mutants 
Category p-value In Category from Cluster 
Number of 
genes 
observed in 
category 
Number of 
genes in 
category 
cellular_component 
[GO:0005575] 
0.001088 
MOH1 YBR196C-A YBR196C-B YBR200W-A 
YBR221W-A YBR296C-A YCL001W-B 
YDL159W-A YDR003W-A YDR034W-B 
YDR169C-A YDR246W-A YFR012W-A 
YGL006W-A YGL041C-B YGL188C-A 
YGR204C-A YHR050W-A YIR018C-A YJL127C-
B YKL068W-A YKL106C-A YGK3  
23 704 
transcription export 
complex 2 [GO:0070390] 
0.001614 SUS1 THP1  2 4 
actin cortical patch 
[GO:0030479] 
0.01464 SLA1 EDE1 SAC6 FKS1  4 57 
nuclear pore [GO:0005643] 0.01552 SUS1 DYN2 THP1 KAP120  4 58 
integral to endosome 
membrane [GO:0031303] 
0.01666 TLG2  1 1 
ornithine 
carbamoyltransferase 
complex [GO:0009348] 
0.01666 ARG3  1 1 
microtubule associated 
complex [GO:0005875] 
0.01666 DYN2  1 1 
vacuole [GO:0005773] 0.01812 
VTC2 VAC7 YNL115C YOL092W RTC1 VMA4 
RNY1  
7 162 
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Category p-value In Category from Cluster 
Number of 
genes 
observed in 
category 
Number of 
genes in 
category 
NatB complex 
[GO:0031416] 
0.03304 MDM20  1 2 
MutSbeta complex 
[GO:0032302] 
0.03304 MSH2  1 2 
6-phosphofructokinase 
complex [GO:0005945] 
0.03304 PFK1  1 2 
endoplasmic reticulum 
palmitoyltransferase 
complex [GO:0031211] 
0.03304 SHR5  1 2 
transcriptionally active 
chromatin [GO:0035327] 
0.03304 THP3  1 2 
mitochondrial matrix 
[GO:0005759] 
0.03731 PIM1 PDB1 PET54 HMI1 MSY1  5 111 
extrinsic to mitochondrial 
inner membrane 
[GO:0031314] 
0.03911 PET54 UPS2  2 19 
Rpd3L-Expanded complex 
[GO:0070210] 
0.03911 TOS4 SIN3  2 19 
nucleoplasm 
[GO:0005654] 
0.0407 SUS1 RTF1 RSA1  3 46 
SAGA complex 
[GO:0000124] 
0.04299 SUS1 HFI1  2 20 
transcription factor TFIIF 
complex [GO:0005674] 
0.04916 TAF14  1 3 
pore complex 
[GO:0046930] 
0.04916 POR2  1 3 
small nuclear 
ribonucleoprotein complex 
[GO:0030532] 
0.04916 BRR1  1 3 
SBF transcription complex 
[GO:0033309] 
0.04916 SWI6  1 3 
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Category p-value 
In Category from 
Cluster 
Number of genes 
observed in category 
Number of genes 
in category 
mitochondrial inner membrane peptidase 
complex [GO:0042720] 
0.04916 SOM1  1 3 
MutSalpha complex [GO:0032301] 0.04916 MSH2  1 3 
MBF transcription complex 
[GO:0030907] 
0.04916 SWI6  1 3 
vacuolar lumen [GO:0005775] 0.04916 RNY1  1 3 
 
 
Table 7: Pools composition – sensitive mutants 
pool (GO terms) deleted gene 
Pool 1: molecular function unknown 1 
YDL026W, YDR370C, YDR426C, HEH2, EAF5, YEL020C, YEL023C, 
YHL044W 
Pool 2: molecular function unknown 2 
YHL012W, YEL025C, YGL081W, YGR127W, YGR139W, VPS62, 
YGR161W-C, YGR213C, YHL006C 
Pool 3: molecular function unknown 3 
ADD37, YMR185W, TRI1, YMR244W, YMR245W, YMR258C, 
YMR259C, YDR352W 
Pool 4: molecular function unknown 4 
YHI9, BZZ1, GVP36, FIS1, ICE2, RAX2, SYM1, REC102, YMR172C-
A 
Pool 5: DNA binding CAD1, GCN4, YAP3, RGM1, RAD14, MRE11, YHM2, YKU70, CST6 
Pool 6: oxidoreductase activity ARA1, EUG1, TDH3, ALD3, ALD2, YMR226C 
Pool 7: membrane transposters ATO3, TPO2, QCR10, TOM5, RPS8A, RPL12B, MRPL44, RLP42A 
Pool 8: methyltransferase / ligase MTQ2, STE14, CTM1, SIZ1, FAA4, RKR1, BUL1 
Pool 9: ATPase / phophatase / signal 
transduction 
IKI1, HSC82, DOG1, TPS3, WSC4, MID2 
Pool 10: peptidase / liase CYM1, RCE1, ARO10, YHR112C, GAD1 
Pool 11: others 1 CBS1, RUB1, PEX7, CAJ1, YHL008C, LIN1, YLR118C, SCJ1, DFM1 
Pool 12. others 2 LSM12, YMR210W, CUE1, YEF1, STP3, GTO1, ETP1, DSK2, BNA7 
 
 
